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ABSTRACT 
 
 
Glial cell line-derived neurotrophic factor (GDNF) family ligands: GDNF, neurturin 
(NRTN), persephin (PSPN) and artemin (ARTN), signal through a receptor complex 
consisting of a glycosyl phosphatidyl inositol (GPI)-linked subunit (GFRα1-4) and 
the transmembrane receptor tyrosine kinase Ret. The GDNF family factors can 
support the survival of various peripheral and central neuronal populations in vitro but 
are required in vivo, particularly for the development of the peripheral nervous system 
(PNS). GDNF has important functions also outside the nervous system, especially in 
kidney development. Activating mutations in the RET gene cause tumours in 
neuroendocrine cells, whereas inactivating mutations in RET are found in patients 
with Hirschsprung’s disease (HSCR) characterized by loss of ganglionic cells along 
the intestine.  
The aim of this study was to examine the in vivo functions of GFRα2 and 
GFRα4 using knockout (KO) mice. Mice lacking GFRα2 grow poorly after weaning 
and have deficits in parasympathetic and enteric innervation. This study shows that 
impaired secretion of the salivary glands and exocrine pancreas contribute to growth 
retardation in GFRα2-KO mice. These mice have a reduced number of intrapancreatic 
neurons and decreased cholinergic innervation of the exocrine pancreas as well as 
reduced excitatory fibres in the myenteric plexus of the small intestine. This study 
also demonstrates that GFRα2-mediated Ret signalling is required for target 
innervation and maintenance of soma size of sympathetic cholinergic neurons and 
sensory nociceptive IB4-binding neurons. Furthermore, lack of GFRα2 in mice results 
in deficient perception of temperatures above and below thermoneutrality and in 
attenuated inflammatory pain response. GFRα4 is co-expressed with Ret 
predominantly in calcitonin-producing thyroid C-cells in the mouse. In this study 
GFRα4-deficient mice were generated. The mice show no gross developmental 
deficits and have a normal number of C-cells. However, young but not adult mice 
lacking GFRα4 have a lower production of calcitonin in thyroid tissue and 
consequently, an increased bone formation rate. Thus, GFRα4/Ret signalling may 
regulate calcitonin production. In conclusion, this study reveals that GFRα2/Ret 
signalling is crucial for the development and function of specific components of the 
peripheral nervous system and that GFRα4-mediated Ret signalling is required for 
controlling transmitter synthesis in thyroid C-cells. 
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REVIEW OF THE LITERATURE 
 
 
Introduction 
 
The mammalian nervous system contains an enormous number of neural cells. During 
embryogenesis the neurons are organized into a functioning nervous system through a 
chain of developmental steps. This complex process involves committing to a neural 
fate, proper migration of the neurons into their destined positions, guiding growing 
neurites into target tissues and controlling the balance between survival and cell 
death. These developmental steps are orchestrated by various environmental cues, 
intrinsic factors and soluble factors secreted from target tissues. Much of this 
development is regulated by so-called neurotrophic factors. During embryogenesis the 
neurotrophic factors are involved in guiding the migration of neural precursors and 
axons towards their proper targets as well as in supporting the survival and 
differentiation of mature neurons. In adult animals, neurotrophic factors take part in 
regulating synaptic plasticity and tissue renewal. Furthermore, neurotrophic factors 
have functions outside the nervous system.  
In most parts of the developing central and peripheral nervous system, neurons 
are produced in excess, with up to twice as many neurons produced as needed by the 
mature animal. However, during the period of programmed cell death the number is 
reduced to correspond to the actual requirement of the innervated tissue (Burek and 
Oppenheim, 1996). Neurons that are able to extend their projections to the correct 
target tissue receive trophic factors allowing them to survive. If a neuron fails to reach 
its target or does not receive a sufficient amount of neurotrophic factors, it will die. 
Neurotrophic factors are able to block the cell death program and can also activate 
specific survival pathways. Although several growth factors have neuronal survival 
effects, the traditional neurotrophic factors include three families: the neurotrophins 
(NGF, BDNF, NT-3 and NT-4/5) (Huang and Reichardt, 2001; Sofroniew et al., 
2001), the neurokines (e.g. LIF, CT-1 and CNTF) (Sariola et al., 1994) and the GDNF 
family of neurotrophic factors (Baloh et al. 2000; Airaksinen and Saarma, 2002; 
Sariola and Saarma, 2003; Enomoto, 2005).  
 
 
Glial cell line-derived neurotrophic factor family 
 
GDNF family ligands 
 
The GDNF family of neurotrophic factors comprises four members: GDNF (glial cell 
line-derived neurotrophic factor), neurturin (NRTN), artemin (ARTN) and persephin 
(PSPN). These molecules form a subgroup in the transforming growth factor beta 
(TGF-β) superfamily and contain seven conserved cysteine residues with the same 
relative spacing found in all members of the TGF-β family (Eigenbrot and Gerber, 
1997). The mature GDNF family proteins are biologically active as glycosylated 
disulphide-bonded homodimers. They are synthesized as precursors (preproproteins) 
with an amino-terminal signal sequence that is cleaved on secretion and a 
prosequence that is cleaved from the mature polypeptide by a furin-like 
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endoproteinase at RXXR cleavage sites (Fig. 1) (Lin et al., 1993; Kotzbauer et al., 
1996; Baloh et al., 1998b; Milbrandt et al., 1998). 
Orthologs of the four GFLs are present in most vertebrate classes. But whereas 
bony fish genomes contain more than four GFL orthologs, one of the ligands, NRTN, 
is absent in clawed frog Xenopus tropicalis and another, PSPN, in the chicken 
genome. So far no GFL orthologs have been found in insects or other invertebrates. 
Thus, the time of origin of GFLs remains unclear, but the first GDNF family ligand 
presumably diverged from existing TGF-β-like proteins (reviewed in Airaksinen et 
al., 2006). 
The founding member of this family, GDNF, was originally purified from a rat 
glial cell line based on its potent survival effect on embryonic midbrain dopaminergic 
neurons (Lin et al., 1993). Later, GDNF was shown to also promote the survival of 
several other central neuron populations, including spinal motoneurons (Henderson et 
al., 1994), locus coeruleus noradrenergic neurons (Arenas et al., 1995), basal 
forebrain cholinergic neurons (Williams et al., 1996) and cerebellar Purkinje cells 
(Mount et al., 1995). Furthermore, GDNF can support peripheral sensory, 
sympathetic, parasympathetic and enteric neurons (Buj-Bello et al., 1995; Heuckeroth 
et al., 1998; Forgie et al., 1999). Many areas of the central and peripheral nervous 
systems in developing and mature mice express GDNF mRNA (Trupp et al., 1995; 
Golden et al., 1999). It is also detected in several peripheral organs, such as the 
embryonic muscle wall of the gastrointestinal tract, kidney mesenchyme, developing 
skin and muscle, whisker follicles and dental mesenchyme (Trupp et al., 1995; 
Suvanto et al., 1996;  Luukko et al., 1997; Sainio et al., 1997; Golden et al., 1999). 
Consequently, GDNF also functions outside the nervous system. For instance, it acts 
as a morphogen in kidney development and regulates the differentiation of adult 
spermatogonial stem cells (Meng et al., 2000; Sariola, 2001). GDNF protein 
expression has been detected at least in the gastrointestinal tract (Peters et al., 1998), 
kidney (Camassei et al., 2003), spinal cord and various brain areas (Kawamoto et al., 
2000). 
 
 
 
Figure 1. Schematic structure of GDNF family ligands. Shown are relative lengths 
(number of amino acids) of pre- and prodomains and the mature protein. Black lines mark 
positions of seven conserved cysteine residues and the RXXR cleavage site is indicated with 
arrowheads. Adapted from Airaksinen et al. (1999). 
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Because of its powerful neuroprotective effects, GDNF has raised interest as a 
potential therapeutic agent for treatment of several neurological diseases (reviewed in 
Airaksinen and Saarma, 2002). Encouraging results obtained from animal 
experiments set great expectations for GDNF in the treatment of Parkinson’s disease. 
Indeed, GDNF has been shown to prevent cell death of dopamine neurons and even to 
promote functional recovery in many animal models of Parkinson’s disease 
(Björklund et al., 2000; Kordower et al., 2000; Åkerud et al., 2001). Unfortunately, 
results from clinical trials have so far been contradictory. Although in an open-label 
trial, local delivery of GDNF directly into the putamen significantly improved motor 
skills of Parkinson’s disease patients (Gill et al., 2003), a recent double-blind, 
placebo-controlled trial failed to confirm these results (Lang et al., 2006). 
NRTN was found in a Chinese hamster ovary cell line as a survival factor for 
cultured sympathetic neurons (Kotzbauer et al., 1996). Mature mouse NRTN protein 
is about 45% identical to mouse GDNF and in addition to sympathetic neurons, it 
promotes the survival of some sensory neuron populations (Kotzbauer et al., 1996), 
enteric neurons (Heuckeroth et al., 1998), parasympathetic submandibular neurons 
(Cacalano et al., 1998), dopaminergic neurons (Kotzbauer et al., 1996), spinal 
motoneurons (Garces et al., 2001) and embryonic basal forebrain cholinergic neurons 
(Golden et al., 2003).  Similarly to GDNF, exogenous NRTN is able to support 
dopamine neuron survival in mouse models of Parkinson’s disease (Horger et al., 
1998; Åkerud et al., 1999), but unlike GDNF it does not induce axonal growth or 
hypertrophy. NRTN transcripts are detected within and outside the nervous system 
during embryonic development and in maturity, e.g. in the brain, skin, many exocrine 
glands, testis, kidney epithelium, circular muscle layer of the gastrointestinal tract, 
lungs and dental epithelium (Widenfalk et al., 1997; Luukko et al., 1998; Golden et 
al., 1999). In rat, NRTN protein has been localized by immunohistochemistry e.g. in 
salivary gland, small intestine and kidney (Xian et al., 1999). 
Human mature PSPN is ~40% identical to GDNF and NRTN and was 
discovered using degenerate PCR. Like all other members of the GDNF family, it 
supports the survival of many central neurons from embryonic rats, including 
midbrain dopaminergic neurons, motoneurons (Milbrandt et al., 1998) and basal 
forebrain cholinergic neurons (Golden et al., 2003) in vitro. But unlike other GDNF 
family ligands, it has not supported any of the peripheral neurons examined 
(Milbrandt et al., 1998). In vivo PSPN may protect the brain from ischaemic insults 
since in mouse and rat models ischaemia-induced neuronal cell death could be 
prevented by exogenous PSPN (Tomac et al., 2002). Furthermore, in a mouse model 
of Parkinson’s disease, the loss of dopamine neurons was prevented by grafting a 
neural stem cell line overexpressing PSPN to the striatal area (Åkerud et al., 2002). 
Two Pspn transcripts, an unspliced form and a functional form, are expressed at very 
low levels in various adult and embryonic tissues in rats (Milbrandt et al., 1998). 
PSPN-like immunoreactivity has been detected in human and rat brain (Quartu et al., 
2005).  
The fourth member of the GDNF family, ARTN was found using database 
searches based on homology to NRTN. It is the most distantly related member of the 
GDNF family, with 36% homology to GDNF at the amino acid level. ARTN can 
support the survival of sensory and sympathetic neurons in culture (Baloh et al., 
1998b), and it is expressed along the migratory routes of sympathetic neuroblasts in 
smooth muscle cells of blood vessels and arteries (Nishino et al., 1999; Honma et al., 
2002). ARTN was shown to prevent neuropathic pain and reverse the associated 
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morphological and neurochemical changes in an animal model (Gardell et al., 2003). 
ARTN can also support midbrain dopaminergic neurons in culture (Baloh et al., 
1998b). However, only low levels of ARTN mRNA have been detected in embryonic 
and adult human brain e.g. in the basal ganglia (Baloh et al., 1998b). 
 
 
GDNF family receptors  
 
All GDNF family ligands can signal through a receptor tyrosine kinase Ret by binding 
first to a co-receptor (GFRα1-4) that is attached to the plasma membrane by a 
glycosyl-phosphatidylinositol (GPI) anchor (Fig. 2). Although GFRα receptors are 
usually bound to the plasma membrane, they can be cleaved by an unknown protease 
or phospholipase to produce soluble forms (Paratcha et al., 2001). GFRα receptors 
have an amino-terminal signal sequence for secretion and a carboxy-terminal 
hydrophobic domain for GPI linkage. GFRα1-3 are proposed to have a domain 
structure of three homologous cysteine-rich domains (D1-D3) joined together by less 
conserved adapter sequences (Airaksinen et al., 1999). In GFRα1, domains 2 and 3 
have been shown to interact with both GDNF and Ret (Leppänen et al., 2004). 
Mammalian GFRα4 is however, smaller, lacking the first amino-terminal cysteine-
rich domain (D1) (Lindahl et al., 2000). Each GDNF family ligand has a preferred 
GFRα co-receptor: GFRα1 for GDNF (Jing et al., 1996;Treanor et al., 1996), GFRα2 
for NRTN (Baloh et al., 1997; Buj-Bello et al., 1997; Klein et al., 1997; Sanicola et 
al., 1997), GFRα3 for ARTN (Baloh et al., 1998a; Naveilhan et al., 1998; Widenfalk 
et al., 1998) and GFRα4 for PSPN (Enokido et al., 1998; Lindahl et al., 2000). At 
least in vitro, NRTN and ARTN bind weakly to GFRα1 and GDNF to GFRα2, but the 
physiological significance of this “cross-talk” is unclear (Airaksinen et al., 1999) (Fig. 
2).  
 Orthologs of the four GFRα receptors are found in all vertebrate classes. 
GDNF receptor alpha like (GRAL), a distant homolog of GFRα, is also present in 
verebrates, but the binding partners for GRAL are so far unknown. Furthermore, a 
GPI-linked protein, Growth-arrest specific 1 (GAS1) may be distantly related to 
GFRα. GFR-like genes exist also in insects (rewieved in Airaksinen et al., 2006). 
Gfra1 mRNA is expressed in several brain areas, the spinal cord and some 
peripheral ganglia and usually in a complementary pattern to GDNF in peripheral 
organs, such as the developing kidney and urethra, whisker follicles and dental 
epithelium, and in a subset of spermatogonia (Luukko et al., 1997; Nosrat et al., 1997; 
Sainio et al., 1997; Golden et al., 1999; Meng et al., 2000). GFRα1 protein has been 
detected in developing rodent gut where it becomes localized to enteric neurons 
(Worley et al., 2000; Gianino et al., 2003). GFRα1 immunoreactivity has also been 
found in human neuromuscular junctions and myelinated nerves (Hase et al., 1999), 
bovine Schwann cells (Hase et al., 2005) and in human trigeminal ganglion neurons 
(Quartu et al., 2006). Furthermore, many regions of rat central nervous system (CNS), 
including spinal motoneurons, substantia nigra and cerebellar cortex show GFRα1 
immunoreactivity (Matsuo et al., 2000). Gfra2 transcripts are detected throughout the 
developing and adult nervous system, including various brain areas, parasympathetic, 
sympathetic and sensory ganglia and the myenteric plexus of the gastrointestinal tract, 
but also in some peripheral organs like the developing tooth and testis (Baloh et al., 
1997; Luukko et al., 1997; Widenfalk et al., 1997; Golden et al., 1999; Rossi et al., 
1999). GFRα2 protein has been localized in parasympathetic nerve fibers in salivary 
and lacrimal glands (Rossi et al., 2000) and in both parasympathetic nerve fibers and 
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glia in endocrine pancreas (Rossi et al., 2005) and pelvic ganglion (Wanigasekara et 
al., 2004). GFRα2 protein expression is also detectable in the newborn and adult gut 
in mouse (Gianino et al., 2003). Furthermore, GFRα2 immunoreactivity has been 
detected in the hippocampal formation (Nanobashvili et al., 2000). Expression of 
Gfra3 is mostly restricted to the peripheral nervous system during development, 
including sensory and sympathetic neurons and Schwann cells (Baloh et al., 1998a; 
Naveilhan et al., 1998; Widenfalk et al., 1998). GFRα3 protein is detected in a 
subpopulation of sensory neurons (Orozco et al., 2001). The mouse Gfra4 gene is 
alternatively spliced during development in a tissue-specific manner, producing GPI-
linked and transmembrane isoforms as well as transcripts with premature stop codons 
(Lindahl et al., 2000).  Although Gfra4 transcripts are found in many embryonic and 
adult tissues, including the nervous system and the testis, the splice form leading to a 
functional GPI-linked isoform of GFRα4 is expressed only in the juvenile thyroid and 
parathyroid glands in mouse. In the newborn mouse and adult mouse thyroid, 
parathyroid, pituitary intermediate lobe and adrenal medulla, a transmembrane 
isoform of GFRα4 is produced instead (Lindahl et al., 2000). Due to lack of a good 
GFRα4 antibody, the localization of GFRα4 protein has not been determined before 
this study (IV). 
 
 
 
 
Figure 2. GDNF family ligand (GFL) receptor complex and interactions. All GFLs activate 
the transmembrane tyrosine kinase receptor Ret via their preferred GFRα receptors (solid 
arrows). Weak “cross-talk” has been observed in vitro (dotted arrows). The mammalian 
GFRα4 lacks the first cysteine-rich domain D1. The GFRα receptors are attached to the cell 
membrane with a GPI anchor. Adapted from Airaksinen and Saarma (2002). 
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Ret (rearranged during transfection), the common signalling receptor for 
GDNF family ligands, was initially discovered as a proto-oncogene, activated by 
DNA rearrangement following transfection of fibroblast cells with DNA from human 
T-cell lymphoma (Takahashi et al., 1985). Ret oncogene encodes a single span 
transmembrane tyrosine kinase with an extracellular ligand binding domain 
containing four cadherin-like repeats and a Ca2+ binding site (Anders et al., 2001), a 
cysteine-rich domain (Takahashi et al., 1988; Takahashi et al., 1989; Iwamoto et al., 
1993; Kuma et al., 1993) and an intracellular domain with tyrosine kinase activity. 
Alternative splicing of Ret gives rise to two major Ret isoforms that differ in their C-
terminal tail. The long isoform of 1114 amino acids (RET51) contains two additional 
tyrosine residues in positions 1090 and 1096 within the carboxyl terminus (Tahira et 
al., 1990) (see also Fig. 4). The short isoform of 1072 amino acids (RET9) is 
important for enteric innervation and renal development (de Graaff et al., 2001), 
whereas RET51 is required for the growth and metabolism of mature sympathetic 
neurons (Tsui-Pierchala et al., 2002a). Ret orthologs are present in all vertebrate 
classes and Ret-like genes have been found also in insects. The Drosophlia D-ret and 
vertebrate Ret genes are expressed in many analogous tissues suggesting similar 
functions. The ligand of D-ret, however, is not known (reviewed in Airaksinen et al., 
2006).  
Ret mRNA is usually expressed similarly to one or several GFRα co-receptors 
and in a complementary pattern to their ligands; in the intestine, for example, Gfra1 
and Ret are expressed in the ganglionic plexuses of the developing gastrointestinal 
tract, while Gdnf is expressed in the muscle layers (Nosrat et al., 1997). Ret gene and 
protein expression is detected in tissues derived from the neural crest, such as 
sympathetic, enteric and sensory neurons, thyroid C-cells and adrenal chromaffin cells 
(Tsuzuki et al., 1995; Belluardo et al., 1999), and in tumours of neural crest origin 
(Takaya et al., 1996).  In the central nervous system (CNS), Ret mRNA and protein 
expression is prominent in dopamine neurons and spinal motoneurons (Tsuzuki et al., 
1995; Nosrat et al., 1997; Trupp et al., 1997; Golden et al., 1999). In addition, Ret 
transcripts and protein are observed in the developing rodent kidney and the 
gastrointestinal tract (Nosrat et al., 1997;Golden et al., 1999;Tsuzuki et al., 
1995;Worley et al. 2000).  
 
 
RET-dependent GDNF family signalling  
 
The original model of GDNF signalling proposed that a GDNF dimer first binds to 
either a monomeric or dimeric GFRα1, and the resulting GDNF/GFRα1 complex 
interacts with two Ret molecules to induce their homodimerization and tyrosine 
phosphorylation (Fig. 3) (Jing et al., 1996). However, at least some Ret molecules 
seem to be pre-associated with GFRα1 before GDNF binding occurs (Eketjäll et al., 
1999). This model requires both Ret and GFRα in the same cells (in cis) and indeed 
often their mRNA expression patterns overlap. However, Gfra receptors are much 
more widely expressed in the nervous system than Ret (Trupp et al., 1997) suggesting, 
that GFRα receptors can signal independently of Ret. Furthermore, GFRα receptors 
that can be cleaved from the cell surface to work as soluble forms might present the 
ligand to Ret located in the membrane of another cell (in trans) (Fig. 3) (Trupp et al., 
1997). 
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Figure 3. GDNF family signalling in lipid rafts (in cis) and outside rafts (in trans). GFRα 
receptors are located in the lipid rafts. Inactive Ret is localized outside rafts, but GFL binding 
to the GFRα receptor recruits Ret to the raft. Recruitment promotes the binding of lipid-
anchored adaptor proteins to the receptor complex and the activation of Src. Activated Ret 
associates preferentially with FRS2 inside the rafts, but outside the rafts Ret is associated 
with Shc. Adapted from Airaksinen and Saarma, 2002. 
 
Lipid rafts are specialized signal transduction platforms that can sort signalling 
molecules, allowing them to interact with each other within the raft and preventing 
interactions with proteins that are excluded from the raft (Simons and Ikonen, 1997). 
The rafts consist of dynamic assemblies of cholesterol and sphingolipids on the outer 
leaflet of the plasma membrane surrounded by a fluid disordered phase of the lipid 
bilayer. Several protein groups, such as GPI-linked proteins, cytoplasmic Src family 
kinases, cholesterol-linked and palmitylated proteins and some transmembrane 
proteins have a high affinity to rafts (Simons and Toomre, 2000). The GPI anchor of 
GFRα receptors localizes them to lipid rafts of the plasma membrane (Poteryaev et 
al., 1999). Inactive Ret is situated outside the rafts, but GDNF binding to GFRα1 
localizes Ret to the lipid rafts and triggers an association with intracellular signalling 
molecules such as Src (Tansey et al., 2000) (Fig. 3). Soluble GFRα1 is also able to 
recruit Ret to the lipid rafts, and the in trans signalling could occur for instance in 
peripheral nerves, where Schwann cells produce GFRα1 while sympathetic and 
sensory axons express Ret (Trupp et al., 1997; Paratcha et al., 2001). Moreover, 
soluble GFRα receptors may function to increase the ligand specificity of Ret 
signalling (Worley et al., 2000). Possibly, during different developmental stages 
neurons require different signalling mechanisms: a GFL-GFRα gradient during cell 
migration but a fixed local source during axonal growth and branching (Airaksinen 
and Saarma, 2002). However, contrary to GFRα1, GFRα4 is unable to recruit Ret to 
rafts upon ligand stimulation, even though PSPN/GFRα4 complex can induce 
phosphorylation of Ret (Yang et al., 2004). Possibly GFRα1 and GFRα4 interact 
differently with other cell surface proteins (Yang et al., 2004). Furthermore, the 
significance of lipid rafts has been questioned, since most of the evidence relies on 
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biochemical extraction studies; so far lipid rafts have not been visualized in living 
cells (Munro et al., 2003). 
Binding of the GFL/GFRα complex brings two transmembrane Ret molecules 
into contact and allows transphosphorylation of specific cytoplasmic tyrosine residues 
to occur. The phosphorylated tyrosine residues (Tyr) of Ret serve as high-affinity 
binding sites for a number of intracellular signalling proteins (Fig. 4). For example, 
Tyr905, Tyr1015, Tyr1062 and Tyr1096 represent docking sites for growth factor 
receptor-bound proteins 7 and 10 (GRB7/10), Phospholipase Cγ (PLCγ), Src 
homology domain containing protein C (Shc) and GRB2, respectively. Tyr1062 is the 
binding site for many adaptor proteins including Shc, fibroblast growth factor receptor 
substrate 2 (FRS2), downstream of tyrosine kinase 4/5 (Dok4/5), insulin receptor 
substrate 1/2 (IRS1/2) and Enigma (Takahashi, 2001; Kurokawa et al., 2003; Ichihara 
et al., 2004). Like other tyrosine kinase receptors, Ret can activate a variety of 
signalling pathways, including p38 mitogen-activated protein kinase (MAPK), c-Jun 
N-terminal kinase (JNK), RAS/extracellular signal-regulated kinase (ERK), ERK5 
and phosphatidylinositol 3-kinase (PI3K)/Akt pathways (Fig. 4). All of these 
pathways are activated mainly through tyrosine residue 1062 (Hayashi et al., 2000). 
After Shc binds to Tyr1062, it further associates with GAB1/2 and GRB2 adaptor 
proteins, leading to activation of PI3K/Akt signalling pathway, and with GRB2/SOS 
complex to activate RAS/ERK signalling pathway. RAS/ERK and PI3K pathways 
result in the activation of transcription factors cAMP responsive element (CREB) and 
nuclear factor κB (NFκB), respectively. Binding of FRS2 to Tyr1062 also leads to the 
RAS/ERK activation via GRB2/SOS adaptor protein complex (Kurokawa et al., 2003; 
Ichihara et al., 2004). How p38MAPK, JNK and ERK5 pathways are activated via 
Tyr1062 is still unclear (Ichihara et al., 2004).  
The Ras/ERK pathway activation has been shown to be crucial for survival 
and differentiation of neurons and for neurite outgrowth (Califano et al., 2000; De 
Vita et al., 2000). Furthermore, it may be involved in branching of the ureteric bud 
(Fisher et al., 2001). The PI3K pathway is also necessary for neuron survival and 
proliferation as well as for lamellipodia formation, which is needed for neurite 
outgrowth (Takahashi, 2001; Fukuda et al., 2002). GDNF-induced lamellipodia 
formation can be regulated by another signalling pathway, too. Protein kinase A 
(PKA) has been shown to phosphorylate serine 696 of Ret following intracellular 
cyclic adenosine monophosphate (cAMP) level increase (Fig. 4). This 
phosphorylation is important for Rac activation and lamellipodia formation (Fukuda 
et al., 2002). Intracellular cAMP concentration is regulated through synthesis of 
cAMP by adenylyl cyclase and breakdown by cyclic AMP phosphodiesterase. 
Trimeric GTP-binding proteins (G proteins) activate adenylyl cyclase via G-protein-
linked receptors. This suggests cross-talk between Ret and G-protein-coupled 
receptors in modulating cytoskeletal structures (Fukuda et al., 2002). The PLCγ 
signalling pathway is known to regulate the intracellular Ca2+ level via inosotol 
(1,4,5)-trisphosphate (IP3) (Airaksinen et al., 1999). Ret signalling also triggers 
activation of Src-family kinases, which induce neurite outgrowth and neuronal 
survival (Tansey et al., 2000). The major binding site for Src appears to be Tyr981 in 
Ret (Fig. 4) (Encinas et al., 2004).  
Although stimulation of Ret activates various survival-promoting pathways, in 
the absence of a ligand Ret can induce apoptosis in certain cell lines. This pro-
apoptotic effect of Ret can be prevented by adding GDNF and may represent a form 
of ligand-independent Ret signalling (Bordeaux et al., 2000). The stimulation of Ret 
triggers different signalling pathways inside and outside rafts. Thus, altering the 
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location of Ret may provide additional diversity to intracellular GDNF family 
signalling. Activated Ret interacts with lipid-anchored adaptor protein FRS2 only 
inside rafts and with soluble Shc mainly outside rafts (Fig. 3). Intriguingly, both of 
these proteins require the same docking site in Ret (Tyr1062), suggesting that 
competition between these two adaptor proteins for the same site in Ret could affect 
the variation observed in intracellular signalling (Paratcha et al., 2001).  
 
 
 
 
Figure 4. Intracellular pathways followed by Ret activation. Transphosphorylation of 
intracellular tyrosine residues (Y) in Ret provide binding sites for various adaptor proteins, 
which specify the down-stream signalling pathways. The most common mutation sites of RET 
in human cancer syndromes MEN2A, MEN2B and FMTC as well as the rearrangment site in 
PTC (see below) are indicated. Adapted from Lindahl (2004). 
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Current data indicate that GDNF signalling is more complex than the original 
model by Jing et al. (1996) suggests. The simplified pathway by which GFLs activate 
Ret via GFRα co-receptors cannot explain all of the biological activities of GFLs. 
Cross-talk with other growth factors and their specific receptors appears to occur. 
Ample evidence suggests that GDNF requires the cooperating factor TGF-β to exert 
its trophic activity in peripheral and some central neurons (Krieglstein et al., 1998; 
Schober et al., 1999; Peterziel et al., 2002); TGF-β may help the ligand to recognize 
its receptor by clustering the GFRα1 molecules to the lipid rafts (Peterziel et al., 
2002). Furthermore GDNF signalling requires cell-surface associated heparan 
sulphate glycosaminoglycans. Without heparan sulphate, Ret phosphorylation does 
not occur and GDNF fails to induce axonal growth and scattering of epithelial cells 
(Barnett et al., 2002). Binding of GDNF to heparan sulphate may serve to concentrate 
the growth factor in the vicinity of its high affinity GFRα receptors and Ret (Barnett 
et al., 2002).  Interestingly, mice lacking heparan sulfate 2-sulfotransferase (an 
enzyme essential in the synthesis of heparan sulphates) resemble Ret-, GFRα1- and 
GDNF-deficient mice as they all lack kidneys (Bullock et al., 1998). Cooperation 
between GDNF family and neurotrophin signalling has also been detected.  
Postnatally, sympathetic neurons lose their nerve growth factor (NGF) 
dependency for survival, instead requiring NGF for soma and neurite growth and to 
assume a mature neurotransmitter phenotype. During this transition period Ret 
phosphorylation is greatly increased in these cells. This increase does not, however, 
require GFLs or GFRα receptors but is induced by NGF. Activation of tropomyosin 
receptor kinase A (TrkA, the high-affinity NGF receptor) by NGF induces 
phosphorylation of the Ret long isoform independently of either GFLs or GFRα 
receptors (Tsui-Pierchala et al., 2002b). Recently, GAS1, a DNA synthesis preventing 
tumor suppressor protein, was proposed to serve as a competitive receptor for GFLs 
(Schueler-Furman et al., 2006). GAS1, which is localized to lipid rafts, exhibits 
homology to GFRα receptors, and the expression patterns of GAS1 and GFRα 
receptors overlap. Schueler-Furman et al. (2006) suggested that competition between 
GAS1 and GFRα co-receptors may in part determine the fate of the cells towards 
apoptosis or cell survival. 
 
 
RET-independent GDNF family signalling 
 
Ret-independent signalling of GDNF family factors had been suspected since GFRα 
receptors are expressed widely in many tissues without Ret (Trupp et al., 1997). 
GDNF binding to GFRα1 has subsequently been found to activate Src-family kinases 
as well as the ERK/MAPK and PLC-γ pathways and the transcription factor CREB in 
cells that do not express Ret (Poteryaev et al., 1999; Trupp et al., 1999). By contrast, 
the NRTN/GFRα2 complex seems unable to signal in the absence of Ret (Pezeshki et 
al., 2001). The finding that exogenous GDNF can increase branching in kidney 
explants from Ret-deficient mice led to the discovery of an alternative signalling 
receptor, Met receptor tyrosine kinase (Popsueva et al., 2003). GDNF could activate 
Met in a cell line lacking endogenous Ret, but the activation was not mediated by 
direct binding of GFRα1/GDNF to Met but via Src family kinases. The in vivo role of 
GDNF/Met signalling remains unclear (Popsueva et al., 2003). Another candidate for 
an alternative GDNF family signalling receptor is neural cell adhesion molecule 
(NCAM), which is widely co-expressed in, for example, the brain and Schwann cells 
with GFRα receptors. When GFRα1 is present, GDNF can bind NCAM with high 
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affinity leading to activation of tyrosine kinase Fyn and focal adhesion kinase FAK in 
the cytoplasm. Furthermore, GFRα1 is able to interact with NCAM and downregulate 
NCAM mediated cell adhesion even in the absence of GDNF (Paratcha et al., 2003). 
In vitro GDNF is able to stimulate Schwann cell migration via NCAM, independently 
of Ret (Paratcha et al., 2003).  
Because the evidence for Ret-independent signalling has been obtained almost 
entirely with cell culture systems its physiological relevance remains unclear. To 
study this issue, mice lacking all Ret-independent GFRα1 expression were generated 
by expressing Gfra1 under the control of Ret promoter in GFRα1-null background 
(Enomoto et al. 2004). These so-called cis-only mice had no deficits in regions where 
trans-signalling has been proposed in vitro, including kidney, enteric and 
motorneurons as well as regenerating nerves. Furthermore, no evidence was found to 
support the existence of GDNF/GFRα1/NCAM signalling in vivo (Enomoto et al., 
2004). However, GFL/GFRα/NCAM signalling might have a role in regulating 
synaptic plasticity in the brain since NCAM -/- mice and GDNF+/- mice have similar 
cognitive defects (Cremer et al., 2000; Gerlai et al., 2001). Furthermore, GFRα1 
mediated GDNF signalling was found to promote in vivo the differentiation and 
migration of cortical GABAergic neurons independently of both Ret and NCAM, 
suggesting alternative transmembrane signalling components (Pozas and Ibanez, 
2005).  
 
 
Derivatives of the neural crest: peripheral nervous system and 
neuroendocrine cells 
 
The vertebrate neural crest is a transient stem cell population that originates from the 
dorsal neuroectoderm at the point of fusion of the neural tube, the organ rudiment that 
consecutively forms the CNS. Neural crest progenitors continue to divide as they 
migrate, following stereotyped routes, until they reach and colonize their final 
destinations. The neural crest progenitors are able to differentiate into cell types as 
diverse as pigment cells, connective tissue, facial cartilage and bone, and such 
neuroendocrine cells as adrenal chromaffin cells and thyroid C-cells and into neurons 
and glia of the PNS (see Fig. 5). While migrating, the initially pluripotent neural crest 
cells become exposed to a sequence of environmental cues which successively limit 
their developmental potential. A number of signals have been identified that bias the 
differentiation of neural crest cells along distinct lineages, including members of the 
Wingless (Wnt), fibroblast growth factor (FGF) and bone morphogenetic protein 
(BMP) families. These instructive signals in turn activate the expression of a network 
of transcription factors that restrict the cellular fate by activating and suppressing 
particular genetic programmes (Sanes et al., 2006). For instance, bone morphogenetic 
proteins (BMPs) trigger a neurogenesis programme in autonomic neurons and induce 
the expression of transcription factors Mash1 (a mouse homologue of the Drosophila 
achaete-scute proneural gene) and Phox2b (paired-like homeobox 2a), which then 
regulate the expression of Phox2a (Lo et al., 1998;Pattyn et al., 1999). Furthermore, 
Phox2a together with Phox2b is able to induce the expression of Ret (Pattyn et al., 
1999).  
The PNS has somatic and autonomic divisions, both of which have motor and 
sensory components. Somatosensory neurons, which innervate the skin, muscle and 
joints, provide information about the outside environment and limb and muscle 
position, whereas viscerosensory neurons convey information about functioning of the 
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visceral organs. The motoneurons innervating voluntary skeletal muscles are 
sometimes also considered part of the PNS, although their cell bodies lay in the CNS 
and they are not derived from the neural crest. The autonomic nervous system 
controls involuntary visceral functions and can be further divided into three distinct 
divisions: sympathetic, parasympathetic and enteric. The sympathetic and 
parasympathetic divisions often display antagonistic effects and together are 
responsible for preserving the animal’s internal homeostasis in a changing 
environment. The sympathetic nervous system participates in the response of the body 
to stress, whereas the parasympathetic acts to conserve the body’s resources and 
restore homeostasis. The enteric nervous system controls the function of the smooth 
muscle of the gut and other digestive organs. The postganglionic parasympathetic 
neurons use acetylcholine as their neurotransmitter, whereas most postganglionic 
sympathetic neurons secrete noradrenaline. While many organs including the exocrine 
and endocrine glands, cardiac muscle, bladder and genitals receive input from both 
the sympathetic and the parasympathetic system, some targets receive innervation 
only from the sympathetic branch. These include the sweat glands, the adrenal 
medulla, the piloerector muscles of the skin and most blood vessels. Various brain 
regions influence the output of the autonomic nervous system usually via the 
hypothalamus, which integrates the received information (Dodd and Role, 1991). 
 
 
Somatic sensory nervous system 
 
Cell bodies of the somatic sensory neurons relaying information from the trunk and 
limbs are located in the dorsal root ganglia (DRG) lateral to the spinal cord, while 
sensory neurons relaying information from the facial area are situated in the cranial 
ganglia. The neurons in the sensory ganglia are bimodal: they send one axon to the 
peripheral tissues, and the other axon relays information from the periphery to the 
dorsal horn of the spinal cord or to the brainstem. The sensory neurons are specialized 
functionally, with different receptors for the detection of innocuous mechanical 
stimuli, such as light touch, vibration and pressure, and for the detection of painful 
stimuli and temperature. Low-threshold mechanoreceptors process external stimuli by 
activating specialized cutaneous and subcutaneous receptors at the body surface. So-
called proprioceptors located in muscles, joints and other deep structures monitor 
mechanical forces that are generated internally. Neurons responsible for the 
perception of innocuous mechanical stimuli are of large diameter and are associated 
with rapidly conducting myelinated axons (Aα and Aβ fibres). Nociceptive neurons 
detect painful thermal, mechanical (high threshold) or chemical stimuli. Nociceptive 
axons terminate in unspecialized free nerve endings in the epidermal and dermal 
layers of the skin, and, being only lightly myelinated (Aδ fibres) or completely 
unmyelinated (C fibres), conduct relatively slowly. Pain can be separated into early 
perception of sharp pain, carried by Aδ fibres, and a later perception of a duller, 
burning quality, which is mediated by C fibres. Many nociceptors tend to respond to 
thermal, mechanical and chemical stimuli and are therefore said to be polymodal, 
while others have more specialized response properties (Meyer et al., 2006). 
The neural crest cells that immigrate into the sensory DRG arise from the 
trunk neural crest (Fig. 5). Activation of Wnt signalling is required to direct the 
multipotent neural crest cells towards a sensory lineage (Lee et al., 2004). The 
migration of the sensory precursors occurs in two waves, producing to distinct subsets 
of sensory neurons. The first wave occurs in the DRG between E9.5 and E11.5, giving 
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rise to large-diameter sensory neurons, including mechanoreceptive neurons that 
express brain-derived neurotrophic factor (BDNF) receptor TrkB and proprioceptive 
neurons that express neurotrophin 3 (NT-3) receptor TrkC. The second wave occurs 
between E10.5 and E13.5 and forms the small-diameter nociceptive neurons that 
express NGF receptor TrkA. Transcription factors of the basic helix-loop-helix 
(bHLH) family, namely neurogenin 1 and 2, are required to generate the different 
subsets of sensory neurons (Ma et al., 1999). While the first wave of progenitors 
belongs to the early migrating neural crest cells, the second wave of progenitors 
originates at least in part from boundary cap cells. These cells arise from ventrally 
migrating neural crest cells and define the points at which axons pass into or out of 
the spinal cord (Maro et al., 2004). The sensory neurons that invade the cranial 
sensory ganglia, including trigeminal ganglia, arise from the neural crest and 
neurogenic ectodermal placodes (Baker and Bronner-Fraser, 2000).  
Majority of sensory DRG neurons in rodents require NGF for survival during 
embryonic development (Silos-Santiago et al., 1995). Animals deprived of NGF/TrkA 
signalling have reduced sensitivity to painful stimuli at birth. About 70-80% of DRG 
neurons, including all nociceptors, are missing in these mice. Postnatally, however, 
half of the small neurons downregulate TrkA and upregulate Ret, the common GDNF 
family receptor (Molliver et al., 1997). The small-diameter DRG sensory neurons that 
mediate nociceptive and thermal responses can be divided into two populations based 
on anatomical, biochemical and physiological properties. About half are postnatally 
NGF-dependent (~40% in mice), express TrkA and synthesize such neuropeptides as 
calcitonin gene-related peptide (CGRP) and substance P. These peptidergic neurons 
project to lamina I and the outer region of lamina II in the spinal cord dorsal horn 
(Snider and McMahon, 1998). Other nociceptors (~30-50%, depending on species) 
lack neuropeptide expression, instead binding the plant isolectin B4 (IB4), expressing 
Ret and projecting to the inner region of lamina II of the spinal cord (Molliver et al., 
1997). Most of these IB4-binding, non-peptidergic neurons also express purinoceptor 
2X3 (P2X3), which is thought to be important in mediating the nociceptive actions of 
adenosine triphosphate (ATP) (Vulchanova et al., 1998). The difference between 
TrkA and Ret-expressing nociceptor populations suggests that they have distinct 
functional properties (Snider and McMahon, 1998). Recent studies imply that the 
peptidergic and non-peptidergic polymodal nociceptor populations also differ in their 
skin innervation patterns (Zylka et al., 2005) and ascending pathways to the brain 
(Braz et al., 2005). Pain consists of both a sensory and an emotional component. IB4 
nociceptors predominantly project to limbic regions of the brain, and thus, are more 
likely to contribute to the motivational, affective dimensions of the pain experience. 
The peptidergic population on the other hand may be more important for the 
discriminative aspects of pain, e.g. localizing the stimulus and verifying whether the 
stimulus is thermal or mechanical (Braz et al., 2005). Furthermore, the two 
populations may differ in their intracellular sensitization mechanisms since a protein 
kinase Cє signalling pathway, which is important in inflammation, was specifically 
activated in IB4-binding nociceptors (Hucho et al., 2005). 
Sensory receptors in the free nerve endings are activated by physical stimuli, 
such as temperature and pressure, and are able to convert the physical stimulus into 
chemical and electrical signals. Transient receptor potential (TRP) receptors are 
temperature-sensitive ion channels that are located within the free nerve endings in 
the skin and are activated by distinct physiological temperatures. Capsaicin, the hot 
ingredient of chili peppers, evokes a sensation of burning pain, and the molecular 
cloning of the capsaicin receptor has led to the identification of the first vanilloid 
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receptor TRPV1 (transient receptor potential vanilloid 1). TRPV1 is also activated by 
temperatures above 43ºC, a temperature most mammals perceive as noxious (Caterina 
et al., 2000; Davis et al., 2000). It is expressed in a subset of peptidergic and isolectin 
IB4-binding neurons in the rat, but in the mouse only a few IB4-positive neurons 
express TRPV1 (Zwick et al., 2002). Based on sequence identity, other 
thermosensitive members of the transient receptor potential (TRP) family of ion 
channels have been cloned and together they are able to detect a wide range of 
temperatures.  
TRPV2 is predominantly expressed in the myelinated medium- to large-
diameter sensory neuron population, and it responds to extremely hot temperatures 
with an activation threshold above 52ºC (Caterina et al., 1999). Innocuous warmth is 
transduced by receptors TRPV3 and TRPV4, which have activation temperatures of 
34-38ºC and 27-34ºC, respectively (Patapoutian et al., 2003; Tominaga and Caterina, 
2004). Both TRPV3 and TRPV4 are expressed in skin keratinocytes and are thought 
to communicate with the epidermal sensory endings to transduce thermal signals (Lee 
et al., 2005; Moqrich et al., 2005). Specific receptors for cool to noxious cold 
temperatures have also been discovered. Menthol receptor TRPM8 responds to 
moderately cool temperatures and is activated at ~25-28ºC, consistent with the cool 
feeling conveyed by menthol products. It is expressed in the sensory neuron fibres of 
the smallest diameter, but does not co-localize with any known nociceptive markers, 
such as CGRP, IB4 and TRPV1 (Patapoutian et al., 2003). Another cold receptor 
TRPA1 (also known as ANKTM1) has a lower activation temperature than TRPM8. 
It is activated by cold at ~17ºC, a temperature that is reported to be painfully cold in 
humans. It is expressed in peptidergic cells within a subset of cells that co-express 
TRPV1. Nociceptors that can respond to both noxious hot and cold could provide a 
molecular explanation for the paradoxical cold phenomenon (Patapoutian et al., 2003; 
Story et al., 2003). 
Many pain states in humans arise partly from actions of chemical mediators on 
nociceptors. A number of endogenous molecules, including bradykinin, serotonin, 
substance P, inflammatory cytokines, growth factors and small molecules such as 
nitric oxide (NO) and ATP are released from damaged cells but also from glial and 
immune cells. Many of these molecules can sensitize nociceptors, which means that 
the threshold for activation is reduced or the responsiveness of the nociceptors to 
suprathreshold stimuli is increased (McMahon et al., 2006). One candidate receptor 
for the transduction of nociceptive signals is P2X3, an ATP-gated cation ion channel 
that is expressed particularly in the GDNF-responsive, IB4-binding population of 
primary sensory neurons. Experiments done using P2X3-deficient mice suggest that 
P2X3 may mediate thermosensation as well as inflammatory pain (Cockayne et al., 
2000; Souslova et al., 2000; Shimizu et al., 2005).  
Virtually all of the IB4-binding DRG neurons are Ret mRNA-positive and the 
majority also express Gfra1 or Gfra2 or both (Bennett et al., 1998, 2000). Only few 
IB4-binding neurons express GFRα3. Most GFRα3-positive neurons belong to the 
peptidergic nociceptor population and are TrkA-positive (Orozco et al., 2001). 
Furthermore, Ret and Gfra1 mRNA are expressed in a subpopulation of large-
diameter DRG cells (Bennett et al., 1998, 2000). Somatosensory target areas, such as 
the epidermis, whisker follicles and tooth, express GFLs Gdnf and Nrtn (Luukko et 
al., 1997; Luukko et al., 1998; Fundin et al., 1999; Golden et al., 1999).  
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Figure 5. Derivatives of the trunk, vagal and sacral neural crest. Somatosensory and 
parasympathetic neurons as well as a population of enteric neurons are derived from the 
trunk neural crest. Sensory neurons colonize the dorsal root ganglia in two waves, generating 
large-diameter and then small-diameter neurons. Sympathetic neurons and adrenal 
chromaffin cells migrate together via the dorsal aorta, where secreted BMP induces the 
expression of Mash1 and Phox2a and Phox2b. Most enteric neurons and thyroid C-cells 
originate from the vagal neural crest. The thyroid C-cells migrate to the ultimobranchial body, 
which fuses with the thyroid rudiment to form the mature thyroid gland. Vagal-derived enteric 
precursors enter the foregut at E11 and colonize the gut along its length. At E13, the enteric 
precursors migrate to pancreatic buds, where they form intrapancreatic ganglia. Some enteric 
neurons also arise from the sacral neural crest. 
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Sympathetic nervous system and the adrenal gland 
 
Preganglionic sympathetic neurons are situated at the thoracic and upper lumbar 
levels of the spinal cord and synapse onto postganglionic neurons in the sympathetic 
chain ganglia, which are situated on both sides of the spinal cord. The postganglionic 
neurons send their axons over relatively long distances to their peripheral targets. 
Sympathetic ganglia at the cervical and upper thoracic level, including the superior 
cervical ganglion (SCG) and the stellate ganglion, innervate various visceral glands as 
well as the heart, lungs, vascular smooth muscle, sweat glands and hair follicles. 
Some preganglionic fibres pass through the sympathetic chain without interruption to 
synapse on neurons of the prevertebral ganglia. These include the celiac ganglion and 
the superior and inferior mesenteric ganglia, which innervate the gastrointestinal 
system and provide sympathetic innervation to the bladder and external genitalia 
(Glebova and Ginty, 2005). 
Postganglionic sympathetic neurons arise from the thoracolumbar level of the 
neural crest (Fig. 5). Together with cells immigrating to the adrenal medulla, these 
cells form the sympathoadrenal lineage. The sympathetic neuroblasts migrate 
ventrally near the dorsal aorta, where they coalesce to form the primordial 
sympathetic chain (reviewed in Anderson, 1993; Glebova and Ginty, 2005). BMPs 
secreted from the dorsal aorta induce (or maintain) the expression of transcriptional 
regulators, including Mash1, Phox2a and Phox2b in the sympathetic progenitors (Lo 
et al., 1998; Goridis and Rohrer 2002; Howard 2005). Mash1 and Phox2 induce the 
expression of the pan-neuronal and noradrenergic markers tyrosine hydroxylase (TH) 
and dopamine β-hydroxylase, which are components required for catecholamine 
biosynthesis from tyrosine (Guillemot et al., 1993; Lo et al., 1998; Pattyn et al., 
1999). Some precursors in the primary sympathetic chain migrate further to generate 
the SCG and prevertebral ganglia and to give rise to adrenal chromaffin cells and 
some enteric neurons in the foregut (Fig. 5) (reviewed in Anderson, 1993; Glebova 
and Ginty, 2005).  
The sympathetic neurons begin to protrude axons already during the formation 
of sympathetic ganglia and extend the axonal projections along blood vessels using 
them as intermediate routes on the way to their final target tissues. NT-3 is expressed 
in blood vessels and has been shown to induce proximal axon outgrowth but not 
axonal initiation (ElShamy et al., 1996; Francis et al., 1999). While the factors 
mediating axonal initiation are not known, a local autocrine growth factor loop 
involving hepatocyte growth factor (HGF) has been proposed (Glebova and Ginty, 
2005). Although NT-3 is needed to mediate the proximal axon growth, the distal 
axonal extension and axonal branching require NGF, which is produced by 
sympathetic target tissues (Korsching, 1993). Furthermore, virtually all sympathetic 
neurons depend on target-derived NGF signalling via TrkA for survival (Francis et al., 
1999; Glebova and Ginty, 2004). However, NT-3 does not appear to directly promote 
sympathetic neuroblast survival in vivo, even though NT-3-deficient mice exhibit 
50% loss of SCG neurons (Ernfors et al., 1994). Instead, the reduced number of 
sympathetic neurons is likely due to impaired early axonal growth and consequent 
impaired ability to obtain target-derived NGF for survival (Kuruvilla et al., 2004). 
While the majority of postganglionic sympathetic neurons are noradrenergic, a 
small subset uses acetylcholine as a neurotransmitter instead (reviewed in Ernsberger 
and Rohrer, 1999; Francis and Landis, 1999). In rodents, targets of these neurons 
include the eccrine sweat glands and periosteum, the connective tissue surrounding 
bone (Landis and Keefe, 1983; Schotzinger and Landis, 1988; Asmus et al., 2000). 
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Similarly to the majority of sympathetic neurons, the innervation of developing sweat 
glands is initially noradrenergic. After gland contact, these neurons downregulate 
noradrenergic properties, such as TH and catecholamine fluorescence, and begin to 
express cholinergic markers, including vasoactive intestinal peptide (VIP) and 
vesicular acetylcholine transporter (VAChT). This transmitter switch occurs during 
the first postnatal weeks in rodents (Ernsberger and Rohrer, 1999; Francis and Landis, 
1999). Transplantation and co-culture experiments with sweat glands have shown that 
this conversion is mediated by a target-derived soluble factor (Schotzinger and 
Landis, 1988; Habecker and Landis, 1994; Guidry and Landis, 1998). Several 
neurokines, including leukaemia inhibitory factor (LIF), ciliary neurotrophic factor 
(CNTF) and cardiotrophin 1 (CT-1), can promote cholinergic differentiation in vitro 
(Glebova and Ginty, 2005). However, in mice lacking LIF, CNTF or both, the 
cholinergic switch occurs normally (Francis et al., 1997). Still, signalling via the 
cytokine LIFRβ/gp130 receptor complex is required for the cholinergic switch in 
culture (Habecker et al., 1997; Francis and Landis, 1999; Duong et al., 2002). NT-3 
and GDNF are other candidates for transmitter phenotype maturation, as they induce 
cholinergic properties in chick sympathetic neurons in vitro (Brodski et al., 2000, 
2002) 
The adrenal gland consists of the medulla and the mesodermally derived 
cortex, which produces glucocorticoids, aldosterone and androgens. The adrenal 
medulla is composed of sympathetic ganglion cells and two populations of chromaffin 
cells that produce catecholamines, either adrenalin or noradrenalin. The adrenal 
medulla receives preganglionic sympathetic innervation, and acetylcholine released 
from the sympathetic nerve endings stimulates the chromaffin cells to secrete 
catecholamines. Together with the sympathetic nervous system, the catecholamines 
constitute the “fight-or-flight” reaction by regulating numerous cardiovascular and 
metabolic processes (Randall et al. 1997). The neural crest progenitor cells arrive at 
the adrenal gland primordium and upregulate the expression of adrenalin-synthesizing 
enzymes phenyletholamine-N-methyl transferase (PNMT) and TH (reviewed in 
Anderson, 1993). The chromaffin cell maturation depends also on the function of 
transcription factors Mash1 and Phox2b, which are expressed by the sympathoadrenal 
progenitors (Huber et al., 2002, 2005) (see Fig. 5). Although an established idea of a 
common sympathoadrenal (SA) progenitor for adrenal chromaffin cells and 
sympathetic neurons exists, it has been challenged by recent studies. Novel evidence 
suggests that chromaffin progenitors are at least in part distinct from neuronal SA 
precursors before invading the adrenal gland (Unsicker et al., 2005)  
Ret is expressed in the SA cells aggregating at the dorsal aorta (Pachnis et al., 
1993). While mouse sympathetic neuroblasts express Ret abundantly at embryonic 
day 11.5 (E11.5) in the SCG and stellate ganglion, only a subpopulation of 
sympathetic neurons expresses Ret during late embryonic and neonatal development 
(Nishino et al., 1999; Enomoto et al., 2001). In the chicken, Ret is selectively 
expressed by the cholinergic subpopulation of the sympathetic chain ganglia 
(Ernsberger et al., 2000; Brodski et al., 2002), but it is not known whether Ret or any 
of the Gfra receptors are expressed by the cholinergic subpopulation of sympathetic 
neurons in mammals. Gfra3 expression is abundant throughout the sympathetic 
nervous system during embryonic development but becomes undetectable in the adult 
(Nishino et al., 1999; Honma et al., 2002). Gfra2 expression is regulated 
developmentally in mouse SCG, being first expressed diffusely by most cells at 
E12.5, then downregulated between E14.5 and E18.5 and again upregulated in a small 
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subpopulation of cells postnatally (Golden et al., 1999). Low levels of Gfra1 are also 
expressed in SCG but in a pattern resembling non-neuronal cells (Baloh et al., 1997).  
Of the GFLs, Artn is expressed in the vicinity of the developing sympathetic 
ganglia and in smooth muscle cells of blood vessels along the migratory routes of 
sympathetic neuroblasts but not in the final target tissues (Nishino et al., 1999; 
Enomoto et al., 2001; Honma et al., 2002). Gdnf, on the other hand, is expressed in 
many sympathetic target tissues (Trupp et al., 1995; Golden et al., 1999). 
Interestingly, Nrtn is expressed in developing and mature sweat glands, the target 
tissue of cholinergic sympathetic neurons in the mouse (Golden et al., 1999).  
In newborn rats and mice Ret is expressed in a subpopulation of chromaffin 
cells in the adrenal medulla (Forander et al., 2001). In the adult rat, adrenal 
chromaffin cells also express high levels of Gfra2, but no Ret (Schober et al. 2000). 
The sympathetic ganglion cells in the adrenal medulla express both Gfra1 and Ret 
(Schober et al., 2000; Forander et al., 2001; Lindahl et al., 2001). However, Ret or 
GFRα1 protein expression was not detected in adult rat adrenal medulla (Schober et 
al., 1999).  Gfra1 and Gfra2 without Ret expression are detected in the nerve fibres of 
the adrenal cortex of the adult rat (Schober et al., 2000). In newborn mice, the 
correctly spliced form of Gfra4 mRNA is expressed in low levels by chromaffin cells, 
whereas in adults Gfra4 transcripts are evenly expressed in all cells of the adrenal 
medulla (Lindahl et al., 2000).  
Of the ligands, Gdnf, Nrtn and Pspn are expressed in the rodent adrenal gland 
(Krieglstein et al., 1996; Xian et al., 1999; Lindahl et al., 2001) and GDNF protein 
expression has been detected in rat adrenal chromaffin cells (Krieglstein et al., 
1998;Schober et al., 1999). The function of GDNF in the adrenal medulla may be to 
offer trophic support for sensory neurons that innervate the chromaffin cells 
(Krieglstein et al., 1996), while the function of PSPN or NRTN in the adrenal gland is 
unknown. 
 
 
Parasympathetic nervous system 
 
Parasympathetic preganglionic axons arise from neurons in the brainstem and sacral 
spinal cord. The preganglionic neurons project to postganglionic neurons in 
parasympathetic ganglia that are situated close to or within the visceral targets. 
Parasympathetic preganglionic nuclei in the brainstem include the Edinger-Westphal 
nucleus, the salivatory nuclei, the dorsal vagal nucleus and the nucleus ambiguous. 
Preganglionic axons from the Edinger-Westphal nucleus project to the ciliary 
ganglion via cranial nerves, and the ciliary ganglion in turn innervates the constrictor 
muscles of the eye. The salivatory nuclei also project through cranial nerves to 
postganglionic neurons in the sphenopalatine, submandibular and otic ganglia, which 
innervate lacrimal, submandibular and sublingual and parotid glands, respectively. 
Parasympathetic stimulation induces lacrimal fluid secretion, which moistens the 
ocular surface, and evokes most of the watery secretion from the salivary glands. The 
dorsal vagal nucleus innervates thoracic and abdominal targets, such as the lungs, 
liver, gall bladder, pancreas and the upper intestinal tract, via the vagus nerve, 
whereas the nucleus ambiguous innervates cardiac ganglia. Parasympathetic 
preganglionic cell axons in the sacral spinal cord leave the spinal cord via ventral 
roots and project via the pelvic nerve to parasympathetic postganglionic neurons in 
the pelvic ganglion plexus. The pelvic plexus innervates the descending colon, 
bladder and external genitalia (Dodd and Role, 1991). 
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Neurons of the intrapancreatic ganglia develop from the vagal neural crest 
cells, first colonizing the foregut (in rats at E11) and then entering the developing 
pancreas that evaginates from the foregut endoderm to form the dorsal and ventral 
pancreatic buds (in mice at E9.5-E10.5) (Schwitzgebel, 2001; Kim and MacDonald, 
2002). Between days E12 and E13, there is a secondary migration of a subset of crest-
derived cells from the duodenum or of a later arriving population of neural crest cells 
into the pancreatic rudiments (Fig. 5). These crest-derived cells aggregate to form a 
network of intrapancreatic ganglia, which can be considered as an extension of the 
enteric nervous system (Kirchgessner et al., 1992). 
The pancreas is a compound gland consisting of both endocrine and exocrine 
tissues, which have specific functions. The endocrine part is organized as islets of 
Langerhans that secrete hormones crucial for balancing blood sugar levels, namely 
insulin, glucagon, somatostatin and pancreatic polypeptide. The exocrine tissue 
produces pancreatic juice that contains bicarbonate and many proteases, lipases and 
carbohydrases essential for digestion. Pancreatic juice is released through the 
pancreatic duct into the duodenum, where it neutralizes intestinal gastric acid 
(Schwitzgebel, 2001; Kim and MacDonald, 2002). The pancreas is richly innervated 
by sympathetic, parasympathetic and sensory branches. Parasympathetic cholinergic 
innervation controls the secretion of islet hormones (including insulin) (Brunicardi et 
al., 1995; Ahren, 2000) as well as the food-induced secretion of pancreatic enzymes 
(Owyang, 1996; Rogers et al., 1996). The parasympathetic fibres originate from the 
intrapancreatic ganglia, which receive preganglionic input from the brainstem via the 
vagus nerve but also direct input from myenteric ganglia (Kirchgessner and Gershon, 
1990).  
Gdnf mRNA is expressed within or around the migrating parasympathetic 
precursors and in parasympathetic tissues, but its expression decreases during 
embryonic development (Golden et al., 1999; Enomoto et al., 2000). Nrtn, however, is 
expressed from E14 onwards in parasympathetic target tissues, such as salivary and 
lacrimal glands and the pancreas (Golden et al., 1999), and is upregulated postnatally 
in salivary and lacrimal glands (Enomoto et al., 2000). Parasympathetic precursors 
express Ret and Gfra1 (Golden et al., 1999; Rossi et al., 2000), but before birth Gfra1 
mRNA is downregulated in many cranial parasympathetic ganglia, including otic, 
sphenopalatine, ciliary and submandibular ganglia. The Ret expression remains 
postnatally and in addition the expression of Gfra2 is upregulated in parasympathetic 
neurons (Enomoto et al., 2000; Rossi et al., 2000).  
 
 
Enteric nervous system 
 
The enteric nervous system acts to some degree independently of the rest of the 
autonomic system, although the gastrointestinal tract also receives input from the 
sympathetic and parasympathetic branches. The network of sensory and motor 
neurons and glia interconnects the different parts of the digestive tract and regulates 
intestinal motility, secretion and transfer of substances across the gut epithelium 
(Grundy and Schemann, 2005). The enteric nervous system innervates not only the 
digestive tract but also the accessory digestive organs such as the pancreas and the 
gall bladder. Nerve fibre bundles connect enteric ganglia together to form two 
plexuses along the intestine, the myenteric plexus and the submucosal plexus. Enteric 
motoneurons reside in the myenteric plexus and innervate both longitudinal and 
circular muscle layers. While the myenteric plexus is present along the entire length 
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of the intestine, the submucosal plexus is present only in the small and large 
intestines. The myenteric plexus or primary plexus consists of myenteric ganglia and 
connective internodal strands. Secondary strands arise from the primary plexus, run 
parallel to the circular muscle and give rise to a deep muscular plexus (dmp) between 
the circular muscle layer and the submucosal plexus (Wilson et al., 1987). The tertiary 
plexus forms a network of thin-calibre fibre bundles in the space between the meshes 
of primary plexus. The tertiary plexus is suggested to be the major site for 
neurotransmission to the longitudinal muscles in the guinea pig (Llewellyn-Smith et 
al., 1993). 
Acetylcholine is the primary transmitter of excitatory motoneurons, but also 
peptide transmitters, such as substance P, are released. Inhibitory motoneurons use 
NO as their primary transmitter instead and such neuropeptides as VIP and 
neuropeptide Y (NPY) as co-transmitters (Sang et al., 1997).  Peristalsis, the intestinal 
motility that propels ingested material, is mediated by a complex pattern of neural 
reflexes involving various transmitters that aim to contract the intestinal muscles. The 
muscle constriction proceeds along the length of the alimentary canal by a 
simultaneous contraction of the longitudinal muscle and relaxation of the circular 
muscle pushing the contents of the intestine in the direction of the peristaltic wave. 
Intestinal neuromuscular transmission is regulated by interstitial cells of Cajal (ICC), 
which form a network that connects myenteric neurons to smooth muscle cells (Lecci 
et al., 2002).  
Enteric precursors that arise from the vagal neural crest migrate from the 
hindbrain region in a rostro-caudal wave along the entire length of the developing 
alimentary tract (Fig. 5). However, most of the enteric neurons in the oesophagus are 
not vagal derived, instead being populated by trunk-level neural crest cells. An 
additional source of enteric neurons is the sacral neural crest, although these cells only 
colonize the postumbilical gut and lie principally in the myenteric plexus (reviewed in 
Newgreen and Young, 2002a). The enteric neural progenitors from the vagal neural 
crest reach the foregut priordium at E9.5-10 in the mouse, and the entire length of the 
gut is populated by E14 (Young et al., 1998). During migration, neural crest cells 
actively proliferate and finally differentiate into a variety of neuronal subtypes 
required for normal intestinal motility and function. Some molecules involved in 
development of the enteric nervous system have been established; for example, sonic 
hedgehog (Shh) and BMPs may regulate the neuronal number and differentiation of 
neural crest cells in the gut, while endothelin-3 and its receptor (endothelin receptor 
B) have a role in the colonization of the distal bowel (Grundy and Schemann, 2005).  
Ret mRNA is expressed in presumptive enteric neuroblasts of the vagal crest 
at E9-11.5 and in the myenteric ganglia of the gut (E13.5-14.5) (Pachnis et al., 1993; 
Tsuzuki et al., 1995; Durbec et al., 1996), but it is not expressed in sacral-derived 
cells (Young et al. 1998). Ret immunoreactivity has been detected in developing rat 
gut from E13.5 onwards and by E15.5 the Ret-immunoreactivity localized to the 
myenteric plexus (Worley et al., 2000). Gfra1 is detectable within the gut wall at E14 
in both neural crest-derived and mesenchymal cells. Postnatally, Gfra1 expression 
weakens and becomes restricted to myenteric and submucosal ganglia. However, 
Gfra2 can be detected in newborn enteric nervous system and continues to be 
expressed strongly in the adult (Gianino et al., 2003).  
Gdnf is expressed at high levels in mouse gut muscle layers during 
embryogenesis. During invasion of the foregut by neural crest progenitors, Gdnf is 
expressed in the mesenchyme of the stomach ahead of the migrating crest cells. As 
the enteric precursors migrate towards the midgut, Gdnf expression rises in a more 
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posterior region (Natarajan et al., 2002). Nrtn mRNA expression begins at E14 in the 
developing intestinal muscle layers and the mucosa (Golden et al., 1999), but during 
postnatal development is concentrated in the circular muscle layer (Widenfalk et al., 
1997).  
 
 
Thyroid C-cells 
 
Thyroid glands reside on either side of the trachea and larynx and are connected by a 
narrow strip of thyroid tissue at the midline. The mature thyroid gland consists of two 
cell types, the thyroid follicular cells and the parafollicular or C-cells. The C-cells are 
distributed unevenly within the gland, with most C-cells located in the middle part of 
the thyroid lobes in small clusters between the follicles. The follicular cells originate 
from endodermal thickening in the ventral wall of the developing pharynx, which 
later forms the primitive thyroid bud (Fig. 5) (Santisteban and Bernal, 2005). The C-
cell precursors arise from the vagal neural crest and migrate through the fourth 
pharyngeal arch mesenchyme to the ultimobranchial body epithelium, which is a 
derivative of the fourth pharyngeal pouch. In the ultimobranchial body, the precursors 
differentiate into mature calcitonin-producing cells (Fontaine, 1979; Santisteban and 
Bernal, 2005). The mature thyroid gland forms when the ultimobranchial body fuses 
with the thyroid rudiment that has migrated caudally to its final position in the 
trachea. In the mouse, this occurs at E14 (Fig. 5). The parathyroids migrate lateral to 
the thyroid gland from the dorsal part of the third pharyngeal pouch (Santisteban and 
Bernal, 2005).  
Thyroid and parathyroid glands produce and secrete hormones involved in 
regulating body metabolism and mineral balance. The thyroid follicular cells 
synthesize triiodothyronine (T3) and thyroxine (T4), which increase metabolic rate 
and body growth. Plasma calcium and phosphate levels, on the other hand, are held in 
homeostasis by the opposing actions of parathyroid hormone (PTH) and calcitonin 
(CT), which regulate the flux of these minerals between plasma and bone. Two types 
of cells are responsible for bone renewal: the osteoblasts regulate bone formation and 
the osteoclasts digest the bone matrix to release calcium. Parathyroid glands secrete 
PTH, which increases serum calcium concentration by stimulating bone resorption, 
whereas thyroid C-cells produce and secrete CT hormone, which lowers the plasma 
calcium concentration towards normal levels by suppressing the activity of the 
osteoclasts. Specific calcium-sensing G-protein-coupled receptors (CaR) on the C-cell 
surface detect the rise in calcium concentration (Brown and MacLeod, 2001; Fudge 
and Kovacs, 2004). The elevated serum calcium levels stimulate the secretion of CT, 
which then binds to its receptors on bone osteoclasts (Nicholson et al., 1986; Lin et 
al., 1991). Consequently, activation of different signalling pathways leads to 
withdrawal of the osteoclasts from the bone surface and reduced production of acid 
and proteolytic enzymes. 
Cell-specific splicing of the CT/CGRPα gene results in production of two 
distinct peptides, CT exclusively by the thyroid C-cells and calcitonin gene-related 
peptide-α (CGRPα) throughout the central and peripheral nervous system (Rosenfeld 
et al., 1983). Although calcitonin has a potent plasma calcium-lowering effect and is 
successfully used to treat conditions associated with increased osteoclast activity, 
such as osteoporosis and Paget’s disease of bone (Civitelli et al., 1988; Zaidi et al., 
2002), its physiological role in bone formation in mammals remains obscure. Not 
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least because removal of the thyroid gland has little effect on long-term calcium or 
bone metabolism and because high serum calcitonin levels in medullary thyroid 
carcinoma do not cause clear osteopetrosis (Zaidi et al., 2002). Surprisingly, mice 
lacking either the CT/CGRPα or CT receptor gene have increased bone mass due to a 
higher bone formation rate and display enhanced responsiveness to exogenous PTH 
(Hoff et al., 2002; Dacquin et al., 2004), suggesting a function for CT in the 
regulation of bone metabolism.  
Like the other neural crest-derived endocrine cell population, adrenal 
chromaffin cells, the C-cells share biochemical and morphological characteristics with 
peripheral neurons. C-cells can synthesize serotonin and serotonin-binding protein 
similarly to enteric neurons (Nunez and Gershon, 1972; Barasch et al., 1987b) and are 
able to extend neurites in response to NGF in culture (Barasch et al., 1987a; Clark et 
al., 1995). The C-cell precursors migrate together with enteric precursors from the 
vagal neural crest, and this has led to the hypothesis that C-cells and enteric neurons 
share a common origin, resembling that of chromaffin cells and sympathetic neurons 
of the SA lineage (Barasch et al., 1987a; Anderson, 1993). Furthermore, Mash1, the 
transcription factor common to autonomic neuronal precursors and chromaffin cells, 
is also required for thyroid C-cell development in rodents (Clark et al., 1995; Lanigan 
et al., 1998). 
Ret mRNA is detected in the posterior pharyngeal arches and in the 
ultimobranchial body (Pachnis et al., 1993; Lindahl et al., 2000) and continues to be 
expressed in adult C-cells, albeit at lower levels (Tsuzuki et al., 1995; Belluardo et al., 
1999; Lindahl et al., 2000). In rat, Ret immunoreactivity is detected in juvenile to 
adult thyroid C-cells (Tsuzuki et al. 1995). Gfra1 transcripts are seen in thyroid 
follicular cells in rat (Belluardo et al., 1999), and Gfra2 mRNA was found in 
developing mouse parathyroids from E12-E18 (Golden et al., 1999). A low level of 
Gfra3 expression was detected in what appeared to be thyroid C-cells (Lindahl et al., 
2000). Gfra4 was observed in the mouse ultimobranchial body together with Ret at 
E12-E16 (Lindahl et al., 2000), and the transcripts encoding the functional GPI-linked 
form of GFRα4 were expressed in the 3-week-old mouse thyroid gland in a pattern 
resembling the C-cell distribution, as well as in the parathyroid gland (Lindahl et al., 
2000). RET and GFRA4 are co-expressed also in human malignant C-cells such as in 
medullary thyroid carcinoma (Lindahl et al., 2000). Of the GFLs, Artn is seen in the 
thyroid gland by Northern blot (Baloh et al., 1998b), and moderate levels of Nrtn 
mRNA are detected in epithelial cells of thyroid follicles in rats (Xian et al., 1999). 
 
 
In vivo functions of GDNF family factors 
 
Genetically engineered mouse models have provided valuable information on the 
physiological significance of GFLs and their receptors. These studies have revealed 
functions for GFLs, mostly in the PNS and in kidney development since only minor 
defects have been reported in the CNS of mice lacking GFLs or their receptor 
components. Gene ablation studies imply a specific pairing of each GFL and 
corresponding GFRα in vivo. Moreover, it appears that virtually all cells and tissues 
affected in GFL and GFRα-deficient mice also express Ret, indicating that Ret is the 
main signalling receptor of GFLs in vivo. Mutations in GDNF family ligand and 
receptor genes, especially in RET, have been found in some human diseases. 
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GDNF/GFRα1/Ret signalling in the development of the enteric and 
parasympathetic nervous systems  
 
Ret- (Schuchardt et al., 1994), GDNF- (Moore et al., 1996; Pichel et al., 1996; 
Sanchez et al., 1996) and GFRα1- (Cacalano et al., 1998; Enomoto et al., 1998) 
deficient mice die soon after birth and share a similar phenotype of absent kidneys 
(see below) and defects throughout the enteric and parasympathetic nervous systems. 
The enteric neurons of the myenteric plexus of the  small and large intestine are 
completely missing in these mice, resembling HSCR in humans (Parisi and Kapur, 
2000). GDNF signalling may be essential not only for the development of the 
structure but also for proper functioning of the enteric nervous system, as 
heterozygous Gdnf+/-, Gfra1+/- and Ret+/- mice all have markedly reduced intestinal 
contractility and neurotransmitter release in vitro (Gianino et al., 2003). Different Ret 
isoforms appear to have distinct functions in vivo, as shown by experiments using 
knock-in mice expressing either RET9 or RET51 (de Graaff et al., 2001). The RET9 
homozygous knock-in mice exhibit aganglionosis of the distal colon similar to HSCR 
and a slightly milder kidney phenotype than the Ret-deficient mice (de Graaff et al., 
2001). However, in RET51 knock-in mice, both the enteric nervous system and the 
kidneys develop normally. The function of GDNF in enteric nervous system 
development has been conserved evolutionarily, as blocking GDNF signalling in 
zebrafish prevents migration of enteric neuron precursors. The fish gdnf receptors: 
gfra1a, gfra1b and ret, are expressed in developing enteric nervous system precursors 
upon these cells entering the gut. Furthermore, the enteric neurons can be eliminated 
in zebrafish by injecting antisense oligonucleotides against ret or the gfra1 
orthologues (Shepherd et al., 2004). In mammals also at least some parasympathetic 
neurons require GDNF signalling during their early development since certain cranial 
parasympathetic ganglia, namely otic and sphenopalatine ganglia, are missing in 
GDNF-, GFRα1- and Ret-KO mice (Marcos and Pachnis, 1996; Enomoto et al., 2000; 
Rossi et al., 2000).  
GDNF is able to support many central neuronal populations in vitro, including 
motoneurons and midbrain dopaminergic neurons, and appears to promote the 
survival and axonal branching of motoneurons also in vivo. A small but significant 
reduction in the number of motoneurons was observed in GDNF- and GFRα1-
deficient mouse embryos (Moore et al., 1996; Sanchez et al., 1996; Cacalano et al., 
1998; Oppenheim et al., 2000). This motoneuron death could be prevented by 
overexpressing GDNF in muscle and by exposing knockout mouse embryos to 
exogenous GDNF in utero (Oppenheim et al., 2000).  Conversely, transgenic mice 
overexpressing GDNF in muscle show a greater number of motoneurons and 
hyperinnervation of neuromuscular junctions (Nguyen et al., 1998), suggesting that 
GDNF-mediated Ret signalling is vital for axonal branching and synapse formation. 
Furthermore, GDNF/Ret signalling may be important postnatally for synaptic 
transmission at the neuromuscular junction (Ribchester et al., 1998).  
Although GDNF supports the survival of embryonic and adult midbrain 
dopaminergic neurons, these neurons develop normally in GDNF-, GFRα1- and Ret-
KO mice (Marcos and Pachnis, 1996; Moore et al., 1996; Sanchez et al., 1996; 
Cacalano et al., 1998; Enomoto et al., 1998). However, these mice die before the 
dopaminergic system fully matures. Thus, GDNF may support the survival of 
dopamine cells postnatally in normal or pathological states (Granholm et al., 2000; Oo 
et al., 2003), or it may regulate the production or release of dopamine (Bourque and 
Trudeau, 2000; Yang et al., 2001; Grondin et al., 2003). In addition, GDNF is 
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proposed to have other functions in the adult brain, such as promoting learning 
behaviour (Gerlai et al., 2001) and reducing biochemical and behavioural changes 
associated with drug addiction (Messer et al., 2000; Airavaara et al., 2006). 
Somatosensory neurons become dependent on GDNF only after birth in vitro 
(Baudet et al., 2000). The number of sensory neurons is consistently unaffected in the 
DRG or trigeminal ganglia of late embryonic (E18.5) GDNF-deficient (Oppenheim et 
al., 2000) or newborn GFRα1-deficient mice (Cacalano et al., 1998; Enomoto et al., 
1998). Postnatally, GDNF may be required for target innervation of at least some of 
the Ret-expressing sensory neurons, as heterozygous Gdnf+/- mice were shown to 
lose myelinated mechanoreceptors in whisker follicles (Fundin et al., 1999). GDNF 
may also be involved in regulating plastic changes after nerve injury since exogenous 
GDNF could prevent and reverse sensory abnormalities in a neuropathic pain model 
in rats (Boucher et al., 2000). Furthermore, GDNF was able to induce regeneration of 
sensory axons back to the spinal cord, and consequently, to rescue sensory function 
after dorsal root injury (Ramer et al., 2000). However, some visceral sensory neurons 
seem to require GDNF for survival because petrosal ganglion neurons are reduced by 
40% in newborn GDNF-deficient mice (Moore et al., 1996; Erickson et al., 2001). 
The chemoafferent sensory neurons of the petrosal ganglion innervate the carotid 
body, an organ involved in breathing control. Thus, newborn mice lacking Ret or 
Gdnf have breathing defects unrelated to the lack of kidneys or impaired enteric 
innervation (Burton et al., 1997; Erickson et al., 2001). Moreover, mutations in Ret 
gene have been associated with congenital hypoventilation syndrome (CCHS or 
Ondine’s curse) (Fitze et al., 2003). 
Despite the generally very similar phenotypes, some differences between the 
Ret-, GFRα1- and GDNF-deficient mice exist. GDNF-KO mice have a 30% reduction 
of SCG neurons (Moore et al., 1996), while mice lacking GFRα1 have normal 
numbers of sympathetic neurons (Cacalano et al., 1998; Enomoto et al., 1998). Ret-
KO mice, on the other hand, have deficits in migration and axonal outgrowth of 
neurons throughout the entire sympathetic chain (Durbec et al., 1996; Enomoto et al., 
2001) and also show loss of the cholinergic population of sympathetic neurons in the 
stellate ganglion (Burau et al., 2004).  
 
 
GDNF/GFRα1/Ret signalling outside the nervous system 
 
In homozygous GDNF-, GFRα1- and Ret-deficient mice, the ureteric bud fails to 
develop, or if it develops it does not branch, and kidneys are absent or remain 
dysplastic and non-functional (Schuchardt et al., 1994; Moore et al., 1996; Pichel et 
al., 1996; Cacalano et al., 1998; Enomoto et al., 1998). Ret-KO mice exhibit mild 
deficits also in neural crest-derived endocrine cells. They have moderate thyroid C-
cell loss (Lindahl et al., 2000) and the adrenal chromaffin cells, although largely 
normal in morphology, produce reduced levels of adrenalin (Allmendinger et al., 
2003). Fascinatingly, mouse models have implied that GDNF/GFRα1/RET signalling 
could serve as a potential target for designing male contraceptives and in treatment of 
hair growth disorders. A role for GDNF in the mouse testis was discovered in a study 
using transgenic loss-of-function and overexpressing models of GDNF. The dosage of 
GDNF produced by Sertoli cells seems to regulate the cell fate decision of 
undifferentiated spermatogonial cells (Meng et al., 2000). Hair growth was enhanced 
in a transgenic mouse line overexpressing Ret in the skin (Kato et al., 2001), and 
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moreover, heterozygous GFRα1-deficient mice exhibited an accelerated regression 
period in the hair follicle cycle (Botchkareva et al., 2000).  
 
 
NRTN/GFRα2 signalling in the development of the parasympathetic and enteric 
neurons 
 
Mice lacking NRTN (Heuckeroth et al., 1999) or GFRα2 (Rossi et al., 1999) are 
viable and fertile with no gross deficits in major organs. They share similar 
impairments in the cholinergic enteric and parasympathetic nervous systems (see 
Table 3). NRTN- and GFRα2-KO mice have defects of varying degree in the 
cholinergic parasympathetic innervation of lacrimal and salivary glands. The 
submandibular ganglion innervating the submandibular and sublingual salivary glands 
has a reduced number of parasympathetic neurons in both NRTN- and GFRα2-KO 
mice (Heuckeroth et al., 1999; Rossi et al., 1999). However, in cranial 
parasympathetic otic and sphenopalatine ganglia, which innervate the parotid gland 
and the lacrimal gland, respectively, the neurons are present but reduced in size (Rossi 
et al., 2000). Furthermore, as a result of the reduced lacrimal gland innervation, both 
NRTN- and GFRα2-deficient mice exhibit diminished tear production and, 
consequently, tend to keep their eyes closed (pseudoptosis) (Heuckeroth et al., 1999; 
Rossi et al., 1999). In addition, the parasympathetic nerve fibres that innervate 
pancreatic islets of Langerhans are reduced in GFRα2-KO mice, leading to impaired 
islet hormone secretion (Rossi et al., 2005). The sacral system supplying the pelvic 
organs with parasympathetic innervation seems to require NRTN/GFRα2/Ret 
signalling as well. Cholinergic parasympathetic innervation of the penis is reduced in 
GFRα2-deficient mice (Laurikainen et al., 2000), and innervation of the epithelium of 
reproductive organs is impaired in both GFRα2- and NRTN-deficient mice 
(Wanigasekara et al., 2004). The cell size of parasympathetic neurons innervating the 
bladder and the vas deferens is also smaller in these mice (Wanigasekara et al., 2004). 
Furthermore, the cholinergic innervation of the heart and the volume of the cardiac 
ganglia are reduced in GFRα2-KO mice (Hiltunen et al., 2000).  
While myenteric ganglion cell number is only slightly decreased, the density 
of the cholinergic, substance P-containing myenteric plexus is reduced in the small 
intestine of both GFRα2- and NRTN-deficient mice, especially in the duodenum. 
Moreover, the motility of the gut is impaired in vitro (Heuckeroth et al., 1999; Rossi 
et al., 1999), and interestingly, the release of the excitatory neurotransmitter substance 
P from the NRTN-deficient mouse colon is also reduced in vitro (Heuckeroth et al., 
1999). This implies that besides supporting enteric innervation, NRTN/GFRα2-
mediated signalling may regulate neurotransmitter release.  
As indicated by the reduction of neuronal number and size in many 
parasympathetic ganglia and in the enteric neural plexus, NRTN/GFRα2-mediated 
signalling appears to be important for target innervation and maintenance of cell size 
(Heuckeroth et al., 1999; Rossi et al., 1999, 2000; Wanigasekara et al., 2004). In fact, 
a switch from GDNF to NRTN dependency is proposed to occur in parasympathetic 
and enteric neurons during late embryonic development: the early neural precursors 
are thought to require GDNF/GFRα1 for migration and proliferation, with 
NRTN/GFRα2 signalling being needed later for the development and maintenance of 
parasympathetic and enteric target innervation (Rossi et al., 2000; Airaksinen and 
Saarma, 2002). Although GFRα2- and NRTN-deficient mice display strikingly similar 
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phenotypes, a clear difference exists. GFRα2-deficient mice show retarded growth 
after weaning, whereas NRTN-deficient mice grow normally (Heuckeroth et al., 
1999; Rossi et al., 1999). The difference between GFRα2- and NRTN-deficient mice 
in growth, even on the same diet and bred to the same background, suggests that 
GFRα2/Ret may be activated by another ligand in vivo (Wanigasekara et al., 2004). 
The cause of this growth retardation in GFRα2-KO mice is discussed in the Results 
and Discussion section of this thesis. 
A physiological role for NRTN/GFRα2/Ret signalling in the sensory nervous 
system has also been proposed. NRTN-deficient mice exhibit a loss of Gfra2 
expressing sensory neurons in DRG and trigeminal ganglion (Heuckeroth et al., 
1999), but in GFRα2-deficient mice no loss of sensory neurons has been reported 
(Rossi et al., 1999; Stucky et al., 2002). However, the diameter but not the number of 
both unmyelinated and myelinated axons in the saphenous nerve was smaller in 
GFRα2-KO mice. Furthermore, electrophysiological studies using acutely isolated 
DRG neuron cultures and skin-nerve preparations from GFRα2-deficient mice 
indicated that GFRα2-mediated Ret signalling regulates noxious heat transduction of 
the IB4-binding subpopulation of sensory neurons (Stucky et al., 2002). The in vivo 
role of GFRα2 in somatosensory neuron function is discussed in the Results and 
Discussion section of this thesis. Although GFRα2-KO mice have no gross deficits in 
CNS structures, GFRα2-mediated signalling appears to have a role in brain functions. 
The response to epileptic stimulus in the hippocampal kindling model was suppressed 
in GFRα2-deficient mice (Nanobashvili et al., 2000), and they also showed impaired 
cognitive abilities in common learning and memory tests (Voikar et al., 2004). 
 
 
GFRα3/ARTN signalling in the migration and initial axon outgrowth of 
sympathetic neurons 
 
ARTN- and GFRα3-KO mice are viable and fertile and show no gross deficits in 
major organs (Nishino et al., 1999; Honma et al., 2002). GFRα3-deficient mice also 
have ptosis, but the mechanism is different from that in mice lacking Gfra2 or Nrtn. 
The superior cervical ganglion that innervates the lid elevator muscle is smaller and 
incorrectly located, and consequently, the sympathetic innervation to the lid muscle is 
reduced (Nishino et al., 1999). In fact, ARTN- and GFRα3-deficient mice have 
abnormalities in the migration and axonal projection pattern of the entire sympathetic 
nervous system. The incorrectly positioned sympathetic neuroblasts are unable to 
obtain neurotrophic support and thus to innervate the target tissues, and eventually, 
some of the sympathetic neurons die (Nishino et al., 1999; Honma et al., 2002). 
ARTN is expressed along the migratory route of the sympathetic neuroblasts in 
smooth muscle cells of blood vessels and may serve as a chemoattractant for the 
sympathetic neuroblasts. Consequently, ARTN/GFRα3/Ret signalling is needed for 
the migration and initial axonal outgrowth of developing sympathetic neurons. 
Although GFRα3 is expressed in nociceptive sensory neurons of DRG and trigeminal 
ganglia (Orozco et al., 2001), no deficits in sensory neurons have been found in either 
ARTN- or GFRα3-KO mice. 
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PSPN may protect the brain from ischaemia 
 
PSPN-deficient mice are viable and fertile, with no gross deficits in any tissues 
examined, including the CNS and the thyroid gland (Tomac et al., 2002). Even 
extensive behavioural tests showed no prominent differences between PSPN-KO mice 
and their wild-type littermates. However, in experimentally induced focal cerebral 
ischaemia, PSPN-deficient mice showed an increased sensitivity to stroke (Tomac et 
al., 2002). Pretreatment of the KO mice with low doses of PSPN before middle 
cerebral artery occlusion markedly reduced the infarction size and enhanced vertical 
locomotor activity, while high doses of PSPN increased the infarction size. Low 
PSPN doses also protected cortical neurons from hypoxia-induced cell death in vitro 
(Tomac et al., 2002). The phenotype of GFRα4-deficient mice is described in the 
Results and Discussion section of this thesis. 
 
 
RET mutations in human diseases 
 
Mutations in RET have been reported in several neural crest disorders. Activating 
mutations of RET are found in the majority of families with multiple endocrine 
neoplasia type 2A and 2B (MEN2A and MEN2B) cancer syndromes and familial 
medullary thyroid carcinoma (FMTC). MEN2A and MEN2B manifest as medullary 
thyroid carcinoma (MTC) originating from the thyroid C-cells and 
pheochromocytoma, which arises from chromaffin cells of the adrenal medulla. In 
addition, hyperparathyroidism develops in some MEN2A patients. MEN2B patients 
show a more complex phenotype, including skeletal abnormalities and enteric and 
mucosal neuromas. FMTC is characterized by MTC as its only disease phenotype. 
RET mutations are found also in sporadic MTC, but in sporadic tumours arising from 
the adrenal or parathyroid glands, RET mutations are rare. In addition, somatic 
rearrangements of RET are involved in papillary thyroid carcinomas (PTC) arising 
from thyroid follicular cells. In MEN2A and FMTC, cysteine substitutions (notably in 
exons 10 and 11) in the extracellular domain induce a ligand-independent 
dimerization and constitutive activation of RET. Conversely, in MEN2B, a single 
substitution of a methionine residue at position 918 in the tyrosine kinase domain 
activates RET by changing its substrate specificity (see Fig. 4) (Hansford and 
Mulligan, 2000; Manie et al., 2001; Takahashi, 2001). Although Ret is expressed in 
various tissues, such as the kidneys and testis (Pachnis et al., 1993; Tsuzuki et al., 
1995), the tumours in MEN2 syndromes are restricted to just a few tissues. GFRα 
receptors have been proposed as modifiers that could restrict the occurrence of 
tumours to specific tissues. GFRA4 is expressed in thyroid C-cells and in MTC, 
indicating that GFRα4 might be necessary for development of C-cell hyperplasia or 
MTC (Lindahl et al., 2001; Vanhorne et al., 2005). Alternatively, other GFRα 
receptors could interfere with the dimerization of mutated RET, thus inhibiting 
tumour formation in tissues unaffected in MEN2 (Kawai et al., 2000). However, some 
FMTC patients have been reported to lack a kidney (Lore et al., 2000) resembling the 
phenotype of Ret-deficient mice. 
Inactivating mutations of RET have been reported in about 50% of patients 
with inherited HSCR, and in 10-20% of sporadic cases of HSCR. HSCR is a 
developmental deficit characterized by lack of innervation along variable lengths of 
the hindgut. The loss of colonic ganglia leads to chronic constipation and intestinal 
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obstruction (Manie et al., 2001; Takahashi, 2001; Newgreen and Young, 2002b). 
Mutated RET may affect both survival and migration of the enteric precursors and 
cause HSCR (Bordeaux et al., 2000). Although GDNF and NRTN mutations have 
been found occasionally in patients with HSCR (Eketjall and Ibanez, 2002), mutations 
in GFRα receptors have not been reported (Borrego et al., 2003). HSCR is a 
multifactorial disease modulated by interactions between two or more disease genes, 
and interactions between Ret and endothelin receptor type B have been suggested 
(Carrasquillo et al., 2002). Ret-deficient mice exhibit intestinal aganglionosis, but the 
phenotype of heterozygous GDNF mutant mice more closely resembles human 
HSCR. These mice show a variable severity of symptoms, ranging from mild 
hypoganglionosis to segmental aganglionosis (Shen et al., 2002). Rarely, both HSCR 
and MEN2A or FMTC may occur in the same patient. This phenotype is associated 
with mutations specifically in cysteine 609, Cys618 or Cys620 that disturb the 
translocation of RET to the cell membrane (Manie et al., 2001; Takahashi, 2001). 
Thus, RET is insufficiently available in the developing enteric nervous system, 
causing apoptosis while at the same time constitutively activated RET causes 
uncontrolled proliferation of endocrine cells.  
 
 36
AIMS OF THE STUDY 
 
 
The general aims of this thesis were to study the physiological functions of GFRα4 
and the novel aspects of GFRα2 function in the PNS using gene deficient mouse 
models. 
 
Specific aims were as follows: 
 
• To identify mechanisms contributing to postnatal growth retardation in GFRα2-
deficient mice  
• To examine the function of GFRα2 in sympathetic cholinergic neurons and their 
target innervation in vivo 
• To determine the function of GFRα2 in sensory neurons and their target 
innervation in vivo 
•      To study the in vivo function of GFRα4 by creating GFRα4-deficient mice 
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MATERIALS AND METHODS 
 
 
Most of the materials and methods used in this study are described in detail in the 
original articles (I-IV). The local ethics committee for animal research at the 
University of Helsinki approved all animal experiments.  
The generation of GFRα4-KO mice is described in detail in study IV. Briefly, 
a fragment of the Gfra4 gene containing exons 2-5 was replaced with a PGKneo 
cassette (neomycin resistance gene under the phosphoglycerate promoter) by 
homologous recombination in R1 embryonic stem cells. Chimeric mice derived from 
these cells were bred to C57NL/6JolaHsd and 129SvHsd females to establish 
heterozygotes. The transgenic offspring were genotyped from tail DNA by PCR. In 
most experiments, hybrids (C57BL/6 x 129Sv) of wild-type and GFRα4-KO 
littermates obtained by inter-crossing the congenic heterozygous parents were used. In 
addition, wild-type and GFRα4-KO mice obtained from homozygous matings were 
used in some of the experiments (IV). 
 
 
Table 1. List of probes used for in situ hybridization.  
 
Probe Species Size Nucleotides Vector 
Gfra1 Mouse 777 bp 1-777 pPT7T3 
Gfra2 Rat 2002 bp 1-2002 pBS 
Gfra3 Mouse 1193 bp 95-1288 pPCDNA3 
Gfra4 3’ EST Mouse 497 bp 1-497 pPT7T3 
Gfra4 5’ exon1a Mouse 127 bp 1-5, 122 bp 5’UTR pPCRII 
Ret Mouse 646 bp 2534-3217 pPBS 
Nrtn Mouse 587 bp 349-936 pCDNA 
 
 
The methods for in situ hybridization and RT-PCR for Gfra mRNA analyses 
are described in the original articles and references therein (I, II, IV). The probes used 
are listed in Table 1. The procedures for immunohistochemical detection and for 
histological stainings are described in detail in the original articles (I-IV). The 
antibodies used are provided in Table 2. The quantification of nerve fibre density is 
described in studies II and III. Cell counts were performed as decribed in studies II, 
III and IV. Cell size distribution analyses are outlined in studies II and III. Co-
localization of different markers using confocal microscopy was used in studies I, III 
and IV. 
Sensitivity to painful stimuli was evaluated using standard behavioural tests. 
More detailed description of hot plate, tail withdrawal, temperature choice, formalin 
and von Frey test for mechanical sensitivity are found in study III and the references 
therein. Chronic inflammatory hyperalgesia was evaluated from mice anaesthetized 
briefly with isofluran and injected with 30 μl of 50% complete Freund’s adjuvant 
(Sigma) under the plantar surface of the left hind paw. Before and 24 and 72 h after 
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the injection, the thermal nociceptive threshold was determined according to the 
method described in Hargreaves et al. (1988). A radiant heat source (Basile plantar 
test, Ugo Basile) located under the floor was targeted at the medial plantar surface of 
the hind paw, and the latency to withdraw from the stimulus was measured. The 
withdrawal latency was determined four times from both the injured and the uninjured 
hind paw at 5-min intervals, with results being expressed as percentage 
hypersensitivity of the injected paw compared with the uninjected paw (unpublished 
data). 
 
 
Table 2. List of primary antibodies and lectin used in immunohistochemistry. 
 
Antibody/ 
Lectin 
Host Source Dilution Study 
Calcitonin Rabbit polyclonal DAKO 1:500 IV 
Calcitonin Goat polyclonal sc-7784 SantaCruz 1:1000 IV 
CGRP Rabbit polyclonal AB5920 Chemicon 1:1000 III 
GFRα2 Goat polyclonal AF429 R&D 1:200 I, II, III 
GFRα4 Goat polyclonal AF1677 R&D 1:400 IV 
Biotin-IB4 
lectin 
Bandeiraea simplifocia Sigma 1:100 III 
nNOS Rabbit polyclonal AB5380 Chemicon 1:500 I 
Peripherin Rabbit polyclonal AB1530 Chemicon 1:500 III 
PGP9.5 Rabbit polyclonal AB1761 Chemicon 1:400 I, II, III 
PGP9.5 Sheep polyclonal AHP508T Serotec 1:50 III 
P2X3 Guinea pig polyclonal AB5896 Chemicon 1:500 III 
PNMT Rabbit polyclonal 22572 DiaSorin 1:1000 unpublished 
data 
Ret Goat polyclonal AF482 R&D 1:20 IV 
S100β Rabbit polyclonal AF482 Swant 1:500 I 
Substance P Rat monoclonal NC1 Medicrop 1:200 I 
TH Rabbit polyclonal AB152 Chemicon 1:200 II 
TH Sheep polyclonal AB1542 Chemicon 1:300 I, data 
unpublished  
TRPV1 Rabbit polyclonal (Tominaga et 
al., 1998) 
1:2000 III 
VAChT Goat polyclonal AB1578 Chemicon 1:800 I, II 
VIP Rabbit polyclonal 11428 Progen 1:100 II 
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Thyroid CT hormone levels were measured by immunoradiometric assay (Rat 
calcitonin IRMA kit, Immutopics, San Clemente, CA, USA) (IV). Bone formation 
rate was estimated using in vivo double calcein fluorescent labelling (Parfitt et al., 
1987; Hoff et al., 2002) (IV). Adrenal gland catecholamine levels were measured 
using high performance liquid chromatography (HPLC). The dissected adrenals were 
homogenized in 100 μl/10 mg 0.4 M percloric acid. The homogenate was centrifuged 
and the supernatant was injected into the HPLC system with a CMA/200 autoinjector 
(CMA Microdialysis). The system for determining noradrenaline and adrenaline 
levels consisted of an ESA CoularrayTM electrochemical detector equipped with a 
model 5014b microdialysis cell and two analytical cells (ESA Inc.) and an ESA 
HPLC pump. The column (Spherisorb ODS2, Waters) was kept at 40ºC with a 
column heater (Croco-Cil, Clouzaeu, InfoLabo). The flow rate of the mobile phase 
(0.1 M NaOH2PO4 buffer, pH 4.0, containing 1 mM octane sulphonic acid, 16% 
methanol and 450 mg/l EDTA) was 1 ml/min.  
The method for measuring in vivo pancreatic secretion and the charcoal transit 
test for gut motility are described in study I. Food and water intake, motor activity, 
basal metabolic rate, wet-mash feeding and faecal-fat analysis were performed as 
described in study I. 
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RESULTS AND DISCUSSION 
 
 
A. GFRα2 in peripheral neurons 
 
The development of intrapancreatic ganglia requires GFRα2 (I) 
 
NRTN signalling via GFRα2 is required for parasympathetic innervation of salivary 
and lacrimal glands (Enomoto et al., 2000; Rossi et al., 2000), suggesting that 
GFRα2-mediated signalling might be necessary for the parasympathetic innervation 
of also other exocrine tissues, such as the pancreas. Expression of Nrtn mRNA 
increases during the late embryonic development of the mouse pancreas (Golden et 
al., 1999). In adult mice the GFRα2 protein was expressed together with several 
neuronal markers, including nitric oxide synthase (NOS), VIP and protein gene 
product 9.5 (PGP9.5), in the intrapancreatic ganglia.  In addition, S100β-positive 
satellite cells surrounding the neuronal cell bodies in intrapancreatic ganglia and the 
terminal Schwann cells surrounding the axons in the exocrine pancreas expressed 
GFRα2 (I; Fig. 3). GDNF has been proposed to bind to a secreted form of GFRα1 that 
is released from the Schwann cell membrane. This GFL/GFRα complex could then 
activate Ret in the axons. The secreted GFRα receptors might act as directional cues 
providing positional information for Ret-expressing axons (Ledda et al., 2002). 
Similarly GFRα2 expressed by glial cells in the exocrine pancreas might act as an 
outgrowth promoting chemoattractant for parasympathetic GFRα2/Ret-expressing 
neurons. 
Whereas in wild-type mice several neuronal clusters were found in the 
exocrine pancreas, virtually no intrapancreatic ganglia were detected in the GFRα2-
deficient mice. The total number of neuronal profiles was significantly reduced (83%) 
in adult GFRα2-KO mice (I; Fig. 4). A small proportion (15%) of NOS-positive 
neurons did not express GFRα2 protein and may represent the population of neurons 
remaining in KO mice (I; Fig. 3c). At P4 there was already a profound (~85%) 
reduction in the pancreatic PGP9.5-positive neuronal profiles and an 80% decrease in 
the number of intrapancreatic ganglia in GFRα2-KO mice. Thus, similarly to 
submadibular parasympathetic ganglia, intrapancreatic ganglia require NRTN/GFRα2 
signalling to achieve the proper number of neurons (Enomoto et al., 2000; Rossi et al., 
2000).  Pancreatic neuronal progenitors arrive at the pancreatic rudiment between 
days E12 and E13 after colonizing the foregut (Kirchgessner et al., 1992). Neuronal 
loss in GFRα2-KO mice appears to occur largely between E15 and birth and is at least 
partly due to increased cell death in both the intrapancreatic and submandibular 
ganglia (Lähteenmäki and Airaksinen, unpublished results).  
In accord with the reduced number of intrapancreatic neurons, a severely 
reduced (~90%) density of cholinergic (acetylcholine esterase (AChE), VAChT- and 
VIP-positive) innervation in the exocrine pancreas of adult GFRα2-deficient mice was 
observed (I; Fig. 4e,f). AChE staining showed an apparently normal cholinergic 
innervation in the islets of Langerhans in the GFRα2-deficient mice (I; Fig. 4e,f), but  
by using the more specific parasympathetic markers VIP and VAChT, the islet 
innervation was also found to be reduced (Rossi et al., 2005).  In contrast to 
cholinergic parasympathetic innervation, the density of sympathetic innervation of the 
exocrine (I; Fig. 4g,h) or endocrine (Rossi et al., 2005) pancreas was not significantly 
different. These results are consistent with previous reports showing reduced or absent 
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cholinergic parasympathetic innervation of various exocrine glands, but intact 
noradrenergic sympathetic innervation (see Table 3) (Rossi et al., 1999, 2000). 
 
 
GFRα2 is needed to maintain the cell size of cholinergic sympathetic neurons (II) 
 
Sympathetic innervation of mouse fore paw sweat glands originates from the stellate 
ganglion and develops between postnatal days P4 and P20 (Francis and Landis, 1999). 
In agreement with an earlier report (Golden et al., 1999), Nrtn mRNA expression in 
postnatal mouse sweat glands was detected. The expression was strong in newborn 
mice, but at P21 hardly exceeded background expression (II; Fig. 1). A subpopulation 
of sympathetic neurons is known to express Ret and Gfra2 transcripts perinatally 
(Nishino et al., 1999; Enomoto et al., 2001), but whether this population represents 
the cells that switch from noradrenergic to cholinergic expression is unknown. In this 
study GFRα2 protein was detected in a subpopulation of P10 stellate ganglion 
neurons in mice (II; Fig. 1). However, in adult mice, the expression was hardly 
detectable. Double-labelling studies with antibody for VIP showed that most if not all 
of the GFRα2-positive neurons were cholinergic (II; Fig. 1I,J), since VIP is co-
expressed with various cholinergic markers (Morales et al., 1995; Asmus et al., 2000).  
GFRα2 immunoreactivity was also detected in cellular structures that were VIP-
negative (II; Fig. 1I,J). These unidentified structures may represent VIP-negative 
neuronal cell bodies, satellite cells or nerve fibres. Thus, the results suggest that at 
least part of the postnatal Gfra2 expression represents the cholinergic population.  
Previous studies have found no neuronal losses in the sympathetic SCG or 
deficits in noradrenergic TH-positive innervation of various tissues in NRTN- or 
GFRα2-deficient mice (Heuckeroth et al., 1999; Rossi et al., 1999, 2000; Enomoto et 
al., 2000; Hiltunen et al., 2000), although NRTN is able to support the survival of 
sympathetic neurons in culture (Kotzbauer et al., 1996). However, expression of 
GFRα2 in the cholinergic sympathetic neurons and Nrtn expression in the sweat 
glands suggest a function for GFRα2 in the development of sympathetic cholinergic 
neurons. We examined the relative density and morphology of VIP-positive stellate 
ganglion neurons between GFRα2-deficient mice and their wild-type littermates. 
Although the number of VIP-positive neuronal profiles did not differ between the 
genotypes, their mean area was significantly reduced in GFRα2-KO mice (II; Fig. 2). 
By contrast, the mean area of TH-positive noradrenergic neuronal profiles was 
unaltered in the KO mice, and moreover, the estimated volume of the stellate ganglion 
itself was not significantly different between the genotypes (II). Thus, consistent with 
previous reports, the number and size of the noradrenergic population of sympathetic 
neurons are not dependent on GFRα2-mediated signalling. 
A subpopulation of sympathetic neurons expresses cholinergic markers 
already during embryonic development, before peripheral target innervation (Schafer 
et al., 1997). Since GDNF and NRTN can induce cholinergic differentiation in 
embryonic chick sympathetic explants (Brodski et al., 2000), GFLs may be required 
for the early cholinergic differentiation of sympathetic neurons in vivo. The number of 
VAChT- and choline acetyltransferase (ChAT)-positive sympathetic cholinergic 
neurons is reduced in newborn Ret-deficient mice, suggesting that early cholinergic 
differentiation of sympathetic neurons requires Ret signalling also in mammals 
(Burau et al., 2004). However, the normal amount of sympathetic cholinergic neurons 
in adult GFRα2-KO mice implies that the ligand for early cholinergic differentiation 
is something other than NRTN. Target tissues of the early cholinergic sympathetic 
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neurons are unknown (Guidry and Landis, 1998), but the early sympathetic 
cholinergic differentiation appears to occur independently of cytokines.  Therefore, 
the early cholinergic neurons may represent a population other than the ones 
innervating sweat glands (Stanke et al., 2000) (see Fig. 6).  
 
 
GFRα2 is required to maintain the cell size of IB4-positive sensory neurons (III) 
 
Ret and Gfra receptor expression in DRG begins during embryonic development and 
continues to adulthood (Golden et al., 1999; Baudet et al., 2000), while Nrtn mRNA is 
expressed in embryonic and adult skin epidermis (Luukko et al., 1998; Golden et al., 
1999). This suggests a function for NRTN in the development of cutaneous 
Ret/GFRα2-positive sensory neurons. In a previous report, GFRα2-mediated 
signalling was proposed to have a function in heat transduction in the IB4-binding 
nociceptors (Stucky et al., 2002). In mouse DRG, GFRα2 was localized almost 
exclusively in the non-peptidergic population of sensory neurons; approximately 80% 
of the IB4-binding neurons expressed GFRα2 and 70% of the GFRα2-positive neurons 
bound IB4 (III; Fig. 1, Table 1). Most GFRα2-positive neurons (~70%) were 
unmyelinated given that they co-localized with peripherin, a marker for unmyelinated 
neurons. The peripherin-negative GFRα2-expressing neurons probably represent 
thinly myelinated nociceptors since their average size did not differ from the size of 
the peripherin-positive GFRα2-expressing neurons (III; Fig. 1G-I). Non-peptidergic 
sensory neurons often express the purinergic receptor P2X3 (Vulchanova et al., 1998). 
We found GFRα2 expression in 85% of P2X3-positive neurons. By contrast, few 
(1.5%) GFRα2-positive neurons expressed CGRP, the marker for the peptidergic 
population (III; Fig. 1, Table 1). In summary, a large majority of small, unmyelinated, 
non-peptidergic neurons in mouse DRG express GFRα2. 
Consistent with normal numbers of unmyelinated axons in cutaneous nerves 
and IB4-binding neurons in DRG cultures, acutely isolated from GFRα2-KO mice 
(Stucky et al., 2002), the density of P2X3-positive neurons in lumbar DRG was 
similar in wild-type and GFRα2-deficient mice (III; Fig. 2). However, in vivo the IB4-
binding and P2X3-positive DRG neuronal profiles were significantly (~30%) smaller 
in GFRα2-KO mice than in their wild-type littermates (III; Fig. 2C,F), which is 
compatible with the smaller calibre of unmyelinated nerve fibres in GFRα2-KO mice 
(Stucky et al., 2002). Accordingly, NRTN-deficient mice have been observed to 
exhibit reduced size of sensory neurons expressing Gfra2 (Heuckeroth et al., 1999), 
but contrary to our data, also the number of Gfra2-expressing DRG neurons was 
reduced in NRTN-KO mice. However, this may be due to downregulation of Gfra2 
expression and not cell death. As expected from the lack of GFRα2 expression in the 
peptidergic DRG neurons in wild-type mice, the CGRP-positive neuronal profiles in 
GFRα2-KO mice were of normal size (III; Fig. 2I). Thus, similar to many autonomic 
cholinergic neurons, GFRα2-mediated signalling (presumably through Ret) is 
required for cell size but not survival of a subpopulation of cutaneous primary sensory 
neurons. 
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B. GFRα2 in peripheral innervation 
 
Reduced innervation of pancreas and small bowel in GFRα2-KO mice (I) 
 
During embryonic development Nrtn mRNA is dispersed in both the muscle layers 
and the mucosa of the intestine (Golden et al., 1999). We found postnatal Nrtn 
expression specifically in the circular muscle layer and GFRα2 protein expression in 
the myenteric and submucosal nerve plexuses and ganglia of newborn and adult 
mouse small intestines (I; Fig. 1). GFRα2 co-localized with a marker for excitatory 
neurons (substance P) in the myenteric ganglia and fibre bundles of the myenteric and 
submucosal layers of the small intestine. Many enteric glial cells within the ganglia 
and in muscle and mucosal layers were also GFRα2 immunoreactive (I; Fig. 1i-k). 
The excitatory AChE-positive fibre density was previously shown to be reduced in the 
small intestine of GFRα2-deficient mice (Rossi et al., 1999). Results in this study 
reveal that the number of SP-containing myenteric neuronal cell bodies was also 
reduced (~35%) in the duodenum of GFRα2-KO mice compared with their wild-type 
counterparts. A severe reduction in the density of SP-positive nerve fibres was found 
in the myenteric ganglion cell layer of the small bowel in GFRα2-deficient mice as 
compared with their littermates (I; Fig. 2). This reduction was most obvious in the 
tertiary plexus suggesting that the actual fibres, and not only the transmitter, are 
reduced. By contrast, the density of SP-positive fibres in the dmp layer was not 
significantly reduced in GFRα2-KO mice (I; Fig. 2c,d).  This implies that a different 
mechanism controls the density of SP-containing fibres in the two layers. A partly 
overlapping GDNF/GFRα1-mediated Ret signalling might explain the restricted 
enteric innervation deficit in GFRα2-KO mice, since many enteric neurons 
(Chalazonitis et al., 1998) express GFRα1 postnatally. The dependence of the tertiary 
plexus on GFRα2 cannot be explained by lack of GFRα2 expression in dmp-
projecting neurons, because GFRα2 is expressed similarly in these two layers. 
Approximately 25% of SP neurons in myenteric ganglia are GFRα2-negative but 
whether they project preferentially to the dmp layer is unknown. 
 
 
GFRα2 is required for sympathetic cholinergic target innervation (II) 
 
The sympathetic innervation of the interdigital sweat glands in fore paw footpads was 
analysed using several cholinergic markers, namely VIP and VAChT antibodies and 
AChE histochemistry (II). Quantification of the VIP- and VAChT-positive 
innervation revealed a significant reduction (~70%) in nerve fibre density in adult 
GFRα2-deficient mice (II; Fig. 3). Moreover, AChE histochemistry, which is not 
completely specific for cholinergic fibres revealed a 50% reduction in sweat gland 
innervation (II; Fig. 3). Similarly to the wild-type mice, the remaining cholinergic 
fibres in the KO mice lacked catecholamine fluorescence (II, data not shown). Pan-
neuronal marker PGP9.5 was used to assess the total innervation density in sweat 
glands, which was as expected reduced. Approximately 20% of the PGP9.5-positive 
nerve fibres in the sweat glands of both wild-type and GFRα2-KO mice were 
VAChT-negative (II, data not shown). These non-cholinergic fibres probably 
represent sensory fibres (Navarro et al., 1995). In contrast to the loss of the majority 
of sympathetic cholinergic fibres in the footpad, noradrenergic (TH-positive) 
sympathetic innervation of blood vessels around sweat glands was intact in GFRα2-
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KO mice (II; Fig. 3G, H). The first sympathetic axons are found in the mouse fore 
paw sweat glands a few days after birth. At that time, the fibres do not express 
cholinergic markers, but are TH-positive and show catecholamine fluorescence 
(Guidry and Landis, 1998). During the first postnatal weeks in rodents the sweat 
gland sympathetic innervation plexus reaches adult density, the gland grows in size, 
and the neurons acquire cholinergic characteristics (Landis and Keefe, 1983). We 
found that the density of cholinergic VAChT-positive fibres in the footpads of 
GFRα2-KO mice at P21 was as much reduced as in the adult. The density of TH-
positive innervation around sweat glands, by contrast, appeared similar between the 
genotypes at P4, indicating that the sympathetic fibres reach the target area 
successfully, but fail to reach normal density during the first postnatal weeks (II). 
In rodents, the only other known postganglionic sympathetic cholinergic target 
is the periosteum, the connective tissue surrounding the bone (Hohmann et al., 1986; 
Asmus et al., 2000). Chemical sympathectomy studies suggest that sympathetic 
periosteal innervation may regulate bone resorption (Hohmann et al., 1986; Cherruau 
et al., 2003). Tracing studies have shown that VIP-positive nerve fibres around the 
ribs and sternum originate from the cholinergic neurons in the thoracic sympathetic 
ganglia. The first sympathetic axons arrive around the periosteum at E17 in the mouse 
(Asmus et al., 2000). Consistent with this, in present study Nrtn transcripts were 
detected around developing bones, including ribs, at E16.5 and in newborn mice (II; 
Fig. 4). A sparse network of varicose cholinergic nerve fibres surrounded the ribs and 
sternum of wild-type mice, but no VIP- or VAChT-positive fibres were found in the 
periosteum of GFRα2-deficient mice (II; Fig. 4 B, D). 
 
 
 
Figure 6. A model for the development of sympathetic cholinergic neurons. 
Development of sympathetic neurons innervating sweat glands requires simultaneous and 
sequential actions of a number of factors. ARTN produced by blood vessels along the 
migratory route of sympathetic neuroblasts is needed for proper migration and proliferation. 
NGF secreted from the target tissue supports the survival of neurons. Proximal axon 
extension is promoted by ARTN via GFRα3/Ret and NT-3 via TrkA. Final target innervation of 
noradrenergic sympathetic neurons requires NGF via TrkA, but cholinergic sympathetic 
neurons may need NRTN signalling through GFRα2/Ret. The switch from noradrenergic (NA) 
to cholinergic (ACh/VIP) may require one or several LIF-like factors via LIFRβ/gp130. 
Adapted from II. 
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Separate factors appear to promote target innervation and cholinergic 
differentiation of sympathetic neurons. Sympathetic axons grow successfully into the 
footpad in mice lacking sweat glands, indicating that the axons do not need any 
factors produced by the sweat glands to reach the target area (Guidry and Landis, 
1995). Furthermore, the normal expression of cholinergic markers in the remaining 
sympathetic nerve cells and fibres innervating the sweat glands in GFRα2-deficient 
mice suggests that NRTN does not act as a target-derived “cholinergic differentiation 
factor” in vivo (II; Fig. 2-3). This is in accord with the current hypothesis that the 
sweat gland-derived cholinergic differentiation factor is an unknown member of the 
cytokine family that signals through the LIFRβ receptor (Cowen et al., 1996; 
Ernsberger and Rohrer, 1999; Francis and Landis, 1999).  
The present results suggest that NRTN may be a general target-derived 
innervation or branching and maintenance factor for postganglionic cholinergic axons 
throughout the autonomic nervous system. Sympathetic cholinergic neurons are able 
to survive in the absence of target innervation in GFRα2-KO mice (II), which is 
consistent with the lack of trophic dependence of postnatal sympathetic neurons 
(Easton et al., 1997). Moreover, sympathetic cholinergic neurons resemble the 
parasympathetic sphenopalatine ganglion neurons that also survive in the absence of 
target innervation in GFRα2-KO mice (Rossi et al., 1999). However, the smaller size 
of the neurons and reduced innervation indicate that NRTN acts as a target-derived 
trophic factor that helps the sympathetic cholinergic neurons to increase or maintain 
cell size and innervation as it does for many other autonomic cholinergic neurons 
(Airaksinen and Saarma, 2002). In contrast to the sympathetic cholinergic population, 
GFRα2 expression is not required for the target innervation of noradrenergic neurons 
in any tissues examined, including footpad blood vessels (II; Fig. 3), the heart 
(Hiltunen et al., 2000) and exocrine glands (Rossi et al., 2000). Sympathetic neurons 
innervating these tissues depend on neurotrophins and express TrkA, but apparently 
do not express GFRα2. 
The development of the sympathetic cholinergic neurons innervating the sweat 
glands and possibly the periosteum appears to require successive or simultaneous 
action of several factors secreted from intermediate and final target tissues (see Fig. 6 
for summary). While the molecular mechanism that triggers axon initiation remains 
unknown, hepatocyte growth factor (HGF) signalling has been proposed (Glebova 
and Ginty, 2005). ARTN produced by nearby blood vessels may promote 
proliferation and migration of sympathetic neuroblasts as well as proximal axonal 
outgrowth (Honma et al., 2002). Another candidate for axon growth is NT-3, which is 
also expressed in blood vessels (Francis et al., 1999). However, neither NT-3 nor 
ARTN is able to induce axon initiation. Some neurons may extend axons before 
migration is complete, implying that soma migration may occur passively, with axons 
leading the way for migrating cell bodies. Thus, the migration defects seen in ARTN-
KO mice may be due to axon growth defects, or conversely, reduced axon extension 
may lead to improper migration (Glebova and Ginty, 2005). On the other hand, NGF 
secreted from the target organs promotes the survival of all sympathetic neurons and 
the final target innervation of many sympathetic noradrenergic neurons (Glebova and 
Ginty, 2004). Final target innervation may also be under inhibitory control by ligands 
such as BDNF or proNGF via low affinity neurotrophic receptor p75. However, the 
final target innervation and axonal branching of the sympathetic cholinergic neurons 
that occurs simultaneously with the growing target tissue may require NRTN. Thus, 
the cholinergic sympathetic neurons apparently switch trophic factor classes initially 
from GFL-Ret signalling to neurotrophin-TrkA signalling, and again back to GFL-Ret 
 46
signalling. During the final target innervation phase, the sympathetic neurons switch 
from a noradrenergic to a cholinergic phenotype, which may require one or more 
unknown (LIF-like) factors that signal through LIFRβ/gp130 and are secreted by the 
target tissues (Ernsberger and Rohrer, 1999; Francis and Landis, 1999). 
 
 
Reduced density of free nerve endings in GFRα2-KO mouse footpad epidermis 
(III) 
 
Although in vitro NRTN is able to support the survival and neurite outgrowth of DRG 
neurons (Kotzbauer et al., 1996; Rossi et al., 1999; Paveliev et al., 2004), primary 
sensory neurons do not seem to require GFRα2-mediated signalling for survival or 
axon growth into the peripheral target area. GFRα2-deficient mice have normal 
numbers of sensory neurons in trigeminal ganglion (Rossi et al., 1999) and DRG (III) 
as well as sensory axons in the saphenous nerve (Stucky et al., 2002).  However, the 
nerve fibre density in the epidermis, visualized using antibody against pan-neuronal 
marker PGP9.5, was clearly reduced (~70%) in GFRα2-KO mice compared to their 
wild-type littermates. In contrast, the density of CGRP-positive nerve fibres in the 
epidermis as well as the dermal fibre density appeared similar between the genotypes 
(III; Fig. 3). Consistent with a previous report (Zylka et al., 2005), we found CGRP 
expression in ~30% of PGP9.5-positive nerve fibres in wild-type mouse epidermis. In 
the GFRα2-KO mouse epidermis, by contrast,  nearly 60% of the remaining PGP9.5-
positive fibres expressed CGRP (III). Since also GDNF is expressed in developing 
mouse skin (Golden et al., 1999), and Gfra1 and Gfra2 are expressed in partly 
overlapping subpopulations of IB4-binding neurons (Bennett et al., 1998), the 
remaining CGRP-negative nerve fibres in GFRα2-KO mouse epidermis may be 
GDNF-dependent. Interestingly, the morphological changes observed in the cutaneous 
sensory neurons of GFRα2-deficient mice (Stucky et al., 2002) are the opposite of 
those found in mice overexpressing GDNF in skin keratinocytes (Zwick et al., 2002). 
The density of IB4-binding in inner lamina II of the spinal cord dorsal horn was 
similar between genotypes, indicating that central target innervation of non-
peptidergic neurons is not affected in mice lacking GFRα2 (III; Fig. 4). 
Reduced density of epidermal sensory nerve endings is often found in human 
neuropathic pain syndromes (Chien et al., 2001), including diabetic and idiopathic 
small fibre neuropathy (Holland et al., 1997) and postherpetic neuralgia (Fields et al., 
1998;Oaklander, 2001). The extent of the nerve fibre loss is positively correlated with 
clinical severity. NRTN/GFRα2-mediated signalling may be altered in these 
conditions since loss of epidermal innervation is often present with no obvious defect 
in the peripheral nerve (Periquet et al., 1999;Herrmann et al., 1999). Furthermore, 
NRTN has been shown to stimulate growth and branching of cutaneous axons in 
diabetic mice (Christianson et al., 2003), and thus, the GFRα2-signalling pathway 
may prove to be a target of therapy for sensory regeneration and persistent pain. 
Peripheral neuropathies usually also involve autonomic and motor components. 
Selective cholinergic dysautonomia involves deficits in both cholinergic autonomic 
and small sensory fibres but not in sympathetic adrenergic fibres (Warner et al., 
2002). The obvious similarity of this rare disease with the phenotype of GFRα2-
deficient mice (II, III) suggests that impaired NRTN/GFRα2 signalling could be 
involved in its pathogenesis. 
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Figure 7. In vivo functions of GDNF family factors in somatosensory neurons. Cell 
bodies of sensory neurons are located in the dorsal root ganglia (DRG). Within the DRG, 
there are subclasses of sensory neurons, including proprioceptive and low-threshold 
mechanosensitive neurons, which have specialized nerve endings (e.g. Pacinian corpuscle; 
Meissner’s corpuscle) and myelinated axons (Aβ). Pain and temperature-sensing neurons 
have lightly myelinated (Aδ) or unmyelinated C-fibres and terminate as free nerve endings.  
Unmyelinated nociceptors (C) can be subdivided into a peptidergic group, which expresses 
CGRP and TrkA, and non-peptidergic group, which binds IB4 and expresses Ret and GFRα2. 
Peptidergic and non-peptidergic unmyelinated nociceptors terminate in different epidermal 
zones and different laminae of the spinal cord. Furthermore, they project to different brain 
areas. NRTN/GFRα2/Ret signalling is essential for the maintenance of soma size, axon 
calibre and terminal innervation of IB4-binding unmyelinated nociceptors as well as for proper 
pain sensation. SB= stratum basalis, SC= stratum corneum, SG= stratum granulosum, SS= 
stratum spinosum, PC= Pacinian corpuscle, MC= Meissner’s corpuscle. Adapted from 
Airaksinen and Saarma (2002), Patapoutian et al. (2003) and Zylka et al. (2005). 
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C. Phenotypes of GFRα2-deficient mice reflect the impaired target 
innervation 
 
Functional deficits contributing to growth retardation in GFRα2-KO mice (I) 
 
After pups are weaned and begin eating solid food, GFRα2-deficient mice exhibit 
growth retardation, which is most pronounced at the age of 4-6 weeks (Rossi et al., 
1999). We analysed several factors that could contribute to the observed impaired 
growth. Secretion of saliva is mostly mediated by parasympathetic innervation of the 
salivary glands (Garrett, 1987). Among other functions saliva assists in eating and 
swallowing by lubricating the mouth and dissolving and diluting the food (Randall et 
al., 1997). GFRα2-KO mice almost entirely lack parasympathetic innervation in the 
sublingual gland and most of the innervation in the parotid gland (Rossi et al., 2000), 
suggesting decreased food-induced saliva secretion in these mice. Consistent with 
this, on a normal dry pellet diet, water intake per body weight was increased (~20%) 
in KO mice compared with their wild-type littermates (I; Fig. 6b). Furthermore, wet 
mash feeding could partially restore the growth of GFRα2-KO mice. The mice gained 
weight faster with the hydrated food but still significantly slower, suggesting that 
other defects besides salivary gland dysfunction contribute to poor growth (I). 
Parasympathetic cholinergic innervation is thought to mediate the 
physiological food-induced secretion of pancreatic enzymes via the vagus nerve 
(Owyang, 1996; Rogers et al., 1996).  The reduced pancreatic innervation in GFRα2-
KO mice may result in an altered pancreatic secretion in vivo. For this a centrally 
acting vagal stimulant, 2-deoxyglucose (2-DG) (Havel and Taborsky, 1989; Li et al., 
1998) was used. While 2-DG significantly increased amylase and protein secretion in 
wild-type, in GFRα2-KO mice, no significant increase in pancreatic secretion was 
elicited (I; Fig. 5). To investigate whether the growth retardation in GFRα2-deficient 
mice could be due to fat malabsorbtion, the mice were fed a high-fat chow and then 
the stool fat was measured. GFRα2-KO mice had a significantly elevated faecal fat 
content compared with wild-type mice (I). This malabsorption in GFRα2-KO mice is 
most likely due to pancreatic insufficiency. 
GFRα2-deficient mice have previously been demonstrated to have impaired 
contractility of the small intestine in vitro (Rossi et al., 1999). Since excitatory 
innervation is crucial for normal gut motility (Sang and Young, 1998), intestinal 
motility in vivo was studied using the charcoal transit test (Bianchi et al., 1983). The 
intragastrically delivered test material travelled a significantly (~25%) shorter 
distance in the GFRα2-KO mice compared with the wild-type littermates. Apparently 
at least part of the weakened in vivo motility is due to the impaired excitatory (SP-
positive) innervation of the longitudinal and circular muscles (I), although impaired 
neurotransmitter release (Heuckeroth et al., 1999) may also contribute to the 
dysmotility in GFRα2-KO mice. These and previous (Rossi et al., 1999) results 
suggest that the growth retardation in GFRα2-deficient mice is at least partly due to 
weakened secretion of pancreatic enzymes and saliva, which leads to poor digestion 
of food and malabsorption. The significance of impaired propulsion in the small 
intestine is less clear, because a slower motility could rather be expected to promote 
growth by giving more time for nutrient absorption. For example, P2X3-deficient 
mice were shown to have impaired peristalsis in the small intestine, but no difference 
in body weight compared to wild-type mice (Bian et al., 2003).  
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Locomotor activity and body temperature were normal in GFRα2-deficient 
mice, but their basal metabolic rate was elevated (I). We estimated the body fat ratio 
by weighing the gonadal fat pads and found that the average weight was 40% lower in 
GFRα2-KO mice than in wild-type mice. Since fat is less metabolically active than 
muscle, a higher muscle-to-fat ratio can lead to the increased basal metabolic rate 
observed in GFRα2-KO mice. Furthermore, the KO mice consumed slightly more 
food per unit of body mass (~8%), which may also be attributable to the increased 
basal metabolic rate (I; Fig. 6). A post-weaning growth retardation phenotype, similar 
to the GFRα2-deficient mice, has been observed in mice lacking muscarinic 
acetylcholine receptor gene for the M3 subtype (Matsui et al., 2000; Yamada et al., 
2001). These M3-deficient mice exhibited impaired in vitro contractility of the small 
intestine as well as low level of induced salivation (Matsui et al., 2000). However, the 
M3-deficient mice were also eating less than their wild type littermates and had 
reduced levels of serum insulin and leptin, a hormone involved in regulating appetite 
and metabolism (Yamada et al., 2001). Regulatory centres in the hypothalamus 
control an animal’s energy homeostasis and food consumption. The hypothalamus is 
also known to express GDNF family receptors, including Gfra2 (Golden et al., 1998). 
Reduced appetite cannot, however, be the reason for the poor growth, since GFRα2-
KO mice ate more than their littermates; the mutant animals try to compensate for 
their malnutrition by increasing food and water intake. This also suggests that, despite 
reduced saliva secretion, the mice have no severe problems in swallowing. Finally, it 
remains unclear why NRTN-deficient mice (Heuckeroth et al., 1999) do not exhibit 
growth retardation on the same diet and breeding background. Possibily, other ligands 
are involved in GFRα2 signalling in vivo (Wanigasekara et al., 2004). It would be 
informative to study whether NRTN-deficient mice have impaired pancreatic 
innervation and function. 
 
 
Reduced inflammatory pain response and enhanced thermal avoidance in 
GFRα2-deficient mice (III) 
 
IB4-binding neurons isolated from GFRα2-KO mouse DRG have defects in heat 
transduction in vitro (Stucky et al., 2002). However, in the hot plate test of thermal 
pain, no significant difference was observed in escape latency between GFRα2-KO 
and wild-type mice at plate temperatures of 52˚C or 49˚C (III; Fig. 5A and not 
shown). Similar results were obtained using mice in hybrid as well as congenic B6 
and 129 backgrounds. In addition, in the tail immersion test, no difference was seen in 
withdrawal latency at a water bath temperature of 52˚C (III; Fig. 5B). However, at 
49˚C, GFRα2-KO mice exhibited significantly shorter withdrawal latencies than wild-
type mice. Moreover, the mutants exhibited much shorter latencies in the cold water 
(4˚C) tail withdrawal test (III; Fig. 5C, D). Thus, the physiological significance of the 
reduced heat transduction observed in vitro (Stucky et al., 2002) remains unclear. 
Alternatively, acutely isolated sensory neuron cultures may represent an injury 
situation (Hökfelt et al., 2006). Our results show that the thermoreceptor TRPV1 is 
not expressed with GFRα2 in mouse DRG, and the density of TRPV1-positive 
neurons is unchanged in GFRα2-KO mice (III; Fig. 1 and not shown), which is 
consistent with the report that IB4-binding neurons do not express TRPV1 in mice 
(Zwick et al., 2002; Woodbury et al., 2004). Consequently, receptors other than 
TRPV1 may transduce noxious heat in GFRα2-positive IB4-binding nociceptors. 
NRTN/GFRα2 signalling in TRPV1-mediated thermal hyperalgesia nevertheless 
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remains possible since peripheral inflammation and neurotrophic factors, including 
GDNF, can increase TRPV1 expression and function in IB4-binding sensory neurons 
(Amaya et al., 2004; Breese et al., 2005).  
The lack of most of the free nerve endings did not have a gross effect on the 
sensing of innocuous warmth, since both wild type and GFRα2-deficient mice 
behaved similarly in a two-temperature choice test (III; Fig. 5E). The remaining 
innervation is probably sufficient to allow normal response to non-noxious 
temperatures. Sometimes normal behaviour is exhibited despite dramatic anatomical 
changes, as demonstrated by a study in which NGF-deficient mice were rescued by 
transgenic expression of NGF in the skin. The response of these mice to noxious 
thermal stimuli recovered fully, although the IB4-binding sensory neuron population 
was only modestly restored (Harrison et al., 2004). Furthermore, we found that both 
genotypes responded similarly to tactile stimulation in a von Frey test of mechanical 
sensitivity (III; Supplementary figure), consistent with a previous report using in vitro 
skin-nerve preparations (Stucky et al., 2002). 
The formalin test is used to assess acute tissue injury-induced pain. 
Subcutaneous injection of formalin causes local tissue damage and activates both 
myelinated and unmyelinated nociceptors (Puig and Sorkin, 1995). The response to 
formalin shows a biphasic behavioural reaction. The early or acute phase is thought to 
reflect direct activation of nociceptors, whereas the late or tonic phase is thought to 
represent central sensitization and/or ongoing inflammation-induced afferent input. 
GFRα2-KO mice have attenuated response to inflammatory pain (III; Fig. 5F). During 
the first phase, GFRα2-KO mice spent an equal length of time licking and shaking the 
affected paw compared to wild type mice. However, in the second phase, the 
formalin-induced pain behaviour was significantly (~60%) reduced in GFRα2-KO 
mice compared with wild-type mice. The formalin-induced swelling did not differ 
between the genotypes, indicating a similar degree of inflammation (III). The intact 
first-phase response in GFRα2-KO mice suggests that functional nociceptor terminals 
mediating the acute response are present in the KO mouse skin. NGF and peptidergic 
nociceptors are known to mediate inflammatory pain (Snider and McMahon, 1998; 
Woolf and Costigan, 1999; Hunt and Mantyh, 2001), but recent studies suggest that 
also non-peptidergic nociceptors take part in the inflammatory processes (Breese et 
al., 2005). Inflammation induces C fibre hyperactivity and ongoing activity of dorsal 
horn neurons (Pitcher and Henry, 2002), both of which are thought to be critical for 
the tonic phase of formalin response (Tjolsen et al., 1992; Puig and Sorkin, 1995; 
Taylor et al., 1995). However, the behavioural pain response involves a network of 
neurons and other cells and is modulated at several levels. Whether the reduced 
formalin-induced inflammatory pain response involves peripheral and/or central 
mechanisms remains to be determined.  
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Figure 8. Response to chronic inflammatory pain. Thermal hyperalgesia to complete 
Freund’s adjuvant is increased 24 h after the injection in GFRα2-KOmice. The results are 
shown as percentage hypersensitivity (injected paw/uninjected paw) before and 24 h 
(*p=0.003 using t-test) and 72 h after the adjuvant injection. The number of animals is 
indicates in parentheses. 
 
Interestingly, formalin-induced inflammatory pain can be inhibited by specific 
P2X3 blockers (Tsuda et al., 1999; McGaraughty et al., 2003) and is attenuated in 
P2X3-deficient mice (Cockayne et al., 2000; Souslova et al., 2000).  Moreover, the 
P2X3-deficient mice exhibit a remarkably similar temperature sensation phenotype to 
the GFRα2-KO mice, including enhanced avoidance of noxious cold and hot 
temperatures in the tail withdrawal test (Shimizu et al., 2005). Contrary to reduced 
formalin-induced pain, the P2X3-KO mice show markedly increased hyperalgesia in a 
model for chronic inflammatory pain (Souslova et al., 2000), and strikingly, our 
unpublished results suggest that GFRα2-deficient mice share this phenotype. Thermal 
hyperalgesia in response to complete Freund’s adjuvant was transiently enhanced 24 h 
after the injection in GFRα2-deficient mice, but after 72 h, the genotypes responded 
similarly to the thermal stimulus (Fig. 8).  Reason for this paradoxical potentiation of 
thermal hyperalgesia in both P2X3-KO (Souslova et al., 2000) and GFRα2-KO mice 
following complete Freund’s adjuvant is not known. Since GFRα2 and P2X3 are co-
localized extensively in mouse DRG, the reduced inflammatory pain response but 
enhanced hyperalgesia and thermal avoidance in GFRα2-KO mice could be caused by 
reduced activation of P2X3. Another possible candidate mediator is bradykinin B1 
receptor. Bradykinin is released during tissue damage and inflammation, and it causes 
an acute sensation of pain via B2 receptors expressed in nociceptors. Following injury 
or inflammation, the B1 receptor becomes upregulated, and this increased expression 
can be induced by NRTN (Vellani et al., 2004). NRTN-KO mice exhibit ocular 
surface inflammation, which resembles the human disease keratoconjunctivitis sicca 
(Song et al., 2003). This as well as the dry eyes phenotype observed in NRTN- and 
GFRα2-deficient mice are most likely due to impaired parasympathetic lacrimal gland 
innervation (Heuckeroth et al., 1999; Rossi et al., 1999). However, decreased tear 
production may also be caused by reduced afferent stimulation of tear production, and 
indeed NRTN-KO mice have been shown to have reduced sensitivity of polymodal 
sensory receptors in the cornea (Song et al., 2003). A summary of work III is 
illustrated in Fig. 7. 
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Table 3. Comparison of phenotypes of GFRα2- and NRTN-deficient mice. 
 
Gene knockout GFRα2-KO NRTN-KO 
Gross 
phenotype 
Viable, fertile, pseudoptosis, growth 
retardation after weaning  
Viable, fertile, pseudoptosis 
Parasympathetic  
Sphenopalatine 
ganglion 
 
Submandibular 
ganglion 
 
 
 
Otic ganglion 
 
 
Ciliary ganglion 
 
 
 
Cardiac ganglia 
 
 
Intrapancreatic 
ganglia 
 
 
Sacral ganglia 
Reduced soma size, lack of lacrimal 
gland innervation 
 
 
42% reduced neuron number and size, 
reduced innervation of submandibular 
and sublingual gland 
 
 
40% reduced neuron number and size, 
reduced innervation of parotid gland 
 
Neuron number not determined, intact 
innervation in pupillary constrictor 
muscle 
 
Reduced innervation of heart, reduced 
volume of the cardiac ganglia  
 
80% reduced neuron number and 
innervation of exocrine and endocrine 
pancreas 
 
Reduced innervation of penis and the 
epithelium of reproductive organs. 
Smaller soma size of neurons 
innervating the bladder and vas 
deferens. 
Reduced soma size, lack of 
lacrimal gland innervation 
 
 
45% reduced neuron 
number, reduced innervation 
of submandibular and 
sublingual gland 
 
Reduced soma size 
 
 
40% reduced neuron number 
 
 
 
Not determined 
 
 
Not determined 
 
 
 
Reduced innervation of the 
epithelium of reproductive 
organs. Smaller soma size of 
neurons innervating the 
bladder and vas deferens. 
Sympahetic 
Cholinergic 
neurons 
 
 
Noradrenergic 
neurons 
 
Reduced soma size, reduced 
innervation of sweat glands and 
periosteum, normal number 
 
Normal size and number and target 
innervation 
 
Not determined 
 
 
 
Normal size and number and 
target innervation 
Enteric Reduced neuron number and reduced 
density of substanceP+ fibers in small 
intestine. Impaired gut motility in vitro 
and in vivo. 
Reduced soma size, neuron 
number and density of 
substance P+ fibers in small 
intestine. Impaired gut 
motility in vitro. Reduced 
release of substance P from 
colon in vitro. 
Sensory 
 
 
 
Reduced soma size of IB4-binding 
sensory neurons, smaller diameter of 
axons in saphenous nerve, reduced 
density of free nerve endings in the 
glabrous skin, loss of heat sensitivity in 
IB4-binding neurons in vitro, reduced 
inflammatory pain response and 
enhanced thermal avoidance in vivo. 
Loss of Gfra2-expressing 
sensory neurons in dorsal 
root – and trigeminal ganglia, 
reduced sensitivity of 
polymodal sensory receptors 
in the cornea. 
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D. In vivo function of GFRα4 (IV) 
 
Generation of GFRα4-KO mice 
 
To generate GFRα4-KO mice, a large part of the Gfra4 gene was deleted using 
homologous recombination in embryonic stem cells and chimeric mice derived from 
these cells were bred to C57BL/6 and 129/Sv females to establish heterozygotes. 
GFRα4-deficient mice were born at the expected Mendelian frequency: of 288 
offspring from heterozygous matings genotyped after weaning, 79 (27%) were wild 
type, 141 (49%) were Gfra4+/- and 68 (24%) were Gfra4-/-. The loss of Gfra4 
expression was confirmed by RT-PCR and with a polyclonal antibody for GFRα4 
from several tissues (IV; Fig. 1, 3J). In situ hybridization with specific mouse RNA 
probes for Gfra1, Gfra2, Gfra3 or Ret did not show signs of upregulation in a one-
week-old GFRα4-KO thyroid (IV; Fig. 4). The GFRα4-KO mice were viable and 
fertile with normal growth and gross behaviour. Basic histological analysis of the 
central nervous system, pituitary gland and testis revealed no differences between 
wild-type and GFRα4-deficient mice. Moreover, no difference was observed between 
GFRα4-KO and wild type-mice in the distribution or number of TH- and PNMT-
positive chromaffin cells in the adrenal medulla (IV, data not shown). 
 
 
GFRα4 and Ret are co-localized exclusively in the juvenile mouse thyroid gland 
 
Gfra4 mRNA is expressed in thyroid C-cells as well as in the parathyroid gland of 
juvenile mice (Lindahl et al., 2000). However, in situ hybridization using a probe 
recognizing the functional signal sequence of mouse Gfra4 gene encoded by exon-1a 
gave a clear signal in the thyroid medulla, but no signal above background in the 
parathyroid gland (IV). Thus, in the thyro-parathyroid gland, only the C-cells express 
Gfra4 transcripts with a functional signal sequence (IV; Fig. 2). There may be tissue-
specific regulatory elements in the Gfra4 promoter, or tissue-specific splicing of a 
short intron between exons 2 and 3 in Gfra4 gene could restrict the production of a 
full-length protein (Lindahl et al., 2000). Addition of this intron results in Gfra4 
transcripts with premature stop codons (Lindahl et al., 2000), and translation of these 
transcripts produces a truncated, soluble protein that is secreted, or alternatively the 
transcripts undergo nonsense-mediated decay (Maquat, 2004). Expression of the 
GFRα4 protein was determined in different tissues known to express Gfra4 mRNA 
(Lindahl et al., 2000) with an antibody for GFRα4 (IV; Fig. 3). GFRα4 
immunoreactivity was seen in most but not all thyroid C-cells in newborn, juvenile 
and adult wild-type mouse, whereas no staining was observed in any other mouse 
tissue examined, including the adrenal gland, testis, pituitary gland, parathyroid gland 
and brain (IV; data not shown). Ret immunoreactivity, by contrast, decreased in the 
thyroid C-cells during development, being prominent at birth and virtually absent in 
adulthood (IV; Fig. 3). A similar decrease in the expression of Ret mRNA has been 
reported (Lindahl et al., 2000). Correctly spliced, full-length Gfra4 mRNA has also 
been detected by RT-PCR in the pituitary intermediate lobe and the neonatal adrenal 
medulla (Lindahl et al., 2000), but  no GFRα4 immunoreactivity was observed in 
these tissues (IV). One cannot, however, exclude the possibility that the GFRα4 
protein is produced in these tissues at levels beyond detection by protein 
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immunohistochemistry. In conclusion, similarly to humans (Lindahl et al., 2001), 
GFRα4 expression appears to be restricted to thyroid C-cells in mice. 
 
 
Normal development of thyroid C-cells in GFRα4-KO mice 
 
In situ hybridization was carried out with specific probes for other GDNF family 
receptors (Gfra1-3 and Ret) in a one-week-old wild-type mouse thyroid. Ret 
expression was seen in distinct clusters in the thyroid medulla, in a similar pattern to 
Gfra4 mRNA expression reported previously (Belluardo et al., 1999; Lindahl et al., 
2000). No expression of Gfra1 or Gfra3 mRNA was detected, but Gfra2 mRNA was 
found in scattered cells across the thyroid gland. Double staining with CT and GFRα2 
antibodies indicated that GFRα2 is not expressed in C-cells. These results show that 
juvenile mouse thyroid C-cells express Ret and Gfra4 but no other GDNF family 
receptors (IV; Fig. 2, 4). As GFRα4 is the only GFRα receptor co-expressed with Ret 
in thyroid C-cells and since newborn Ret-deficient mice have ~37% less CT-positive 
cells than their wild-type littermates (Lindahl et al., 2000), we investigated whether 
GFRα4 is necessary for C-cell development. Immunostaining with an antibody 
against CT (a specific marker of C-cells) showed no differences in the morphology, 
distribution or number of thyroid C-cells between genotypes in newborn or adult mice 
(IV; Fig. 5). Thus, even if GFRα4 seems to be the only co-receptor expressed in 
thyroid C-cells with Ret in newborn and juvenile mice it is not needed for the early 
development of these cells. Although Gfra1 is not expressed in thyroid C-cells 
postnatally (IV; Fig. 4), in situ hybridization of E12 embryos showed that the 
expression patterns of Ret and Gfra1 mRNAs (in addition to Gfra4) (Lindahl et al., 
2000) overlap in the ultimobranchial body, the structure from which the C-cells arise 
(IV; Fig. 6). Thus, the Ret-dependent subpopulation of C-cells may require signalling 
through GFRα1 during embryonic development. Confirmation of this hypothesis 
awaits studies using GFRα1 or GFRα1/GFRα4 double KO mice. The physiological 
significance of GFRα4 in the ultimobranchial body remains unclear, particularly as it 
is not known whether the Gfra4 mRNA expressed in the mouse embryo at E12 codes 
for the functional form of GFRα4.  
 
 
Reduced thyroid calcitonin levels and increased bone formation rate in newborn 
and juvenile GFRα4-KO mice 
 
In contrast to normal C-cell development, the newborn and 3-week-old GFRα4-
deficient mice had significantly reduced thyroid CT levels. Using an 
immunoradiometric assay, thyroid tissue CT levels were reduced by 60% in newborn 
and by 45% in juvenile GFRα4-KO mice (IV; Fig. 7). By contrast, thyroid CT levels 
in adult mice were similar between genotypes. These results were obtained from mice 
in both B6 and hybrid backgrounds. However, this phenotype appeared to be 
dependent on genetic background, since newborn GFRα4-KO mice in a hybrid 
129/B6 background had an even more pronounced reduction in CT levels (80%), but 
newborn mice in a B6 background had almost similar CT levels between the 
genotypes. Likewise, a background effect was proposed for the incomplete penetrance 
of the ptosis phenotype in ARTN and GFRα3-KO mice (Honma et al., 2002). 
Furthermore, serum CT levels were reduced by ~40% in juvenile GFRα4-KO mice in 
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a hybrid 129/B6 background, but this did not reach statistical significance (data not 
shown). These results indicate an active role for GFRα4 in modulating CT production, 
and it is unlikely that the reduced CT levels are secondary due to developmental 
effects since the reduction was seen specifically in young, not adult, mice (IV; Fig. 7). 
Moreover, the lower thyroid CT levels in juvenile GFRα4-KO mice cannot be 
attributed to increased CT secretion since serum CT levels were also reduced (IV).  
Because GFRA4 and RET mRNAs are co-expressed also in human thyroid C-cells 
(Lindahl et al., 2001), GFRA4/RET signalling may enhance CT production in 
humans. Although exogenous CT is known to inhibit bone resorption (Friedman and 
Raisz, 1965), CT, as well as CT receptor-deficient mice display an increased bone 
formation rate compared with their wild-type littermates (Hoff et al., 2002; Dacquin et 
al., 2004). Consistent with this, we observed a similar but milder increase (~20%) in 
bone formation in juvenile GFRα4-KO mice (IV; Fig. 8).  
In contrast to CT levels, we found that the tissue adrenalin (WT = 14 ± 2 
μg/ml, KO = 20 ± 1 μg/ml, p = 0.02, n = 9 for both genotypes) and noradrenalin (WT 
= 7 ± 1 μg/ml, KO = 11 ± 1 μg/ml, p = 0.02, n = 9 for both genotypes) levels 
measured by HPLC were slightly but significantly elevated in GFRα4-deficient 
adrenal glands (Hiltunen et al., 2001). However, the mechanism remains unclear, 
since we could not detect GFRα4 immunoreactivity in the mouse adrenal gland at any 
time point examined (IV, data not shown). But the increase in adrenalin and 
noradrenalin levels may be due to altered synthesis or release or chronic stress 
causing a compensatory upregulation of catecholamine syntesis. In contrast, Ret-
deficient mice showed a ~30% reduced adrenaline, but not noradrenaline levels 
(Allmendinger et al., 2003).  
GFRα4 is required for CT production in young mice only likely because 
expression levels of Ret mRNA (Lindahl et al., 2000) and protein (IV; Fig. 3) are 
higher in newborn and juvenile C-cells than in adult C-cells. In contrast, GFRα4 
protein expression appears to persist in adult C-cells. Moreover, semiquantitative RT-
PCR analysis amplifying the full-length Gfra4 mRNA suggests that the relative 
expression of the functional GPI-anchored isoform (Yang et al., 2004) and the 
transmembrane isoform (Yang et al., 2005) of mouse GFRα4 is similar between 
newborn, juvenile and adult thyroid C-cells. The mechanism of GFRα4-mediated Ret 
signalling in regulating thyroid CT levels remains to be elucidated. One possibility 
suggested by our preliminary results is that it regulates CT mRNA levels: thyroid 
tissue CT mRNA expression appears to be reduced in juvenile GFRα4-KO mice 
compared with wild-type controls (IV; Suppl. Fig. 1). Signal transduction pathways 
and mechanisms that regulate CT production are not well known. Increased calcium 
levels stimulate CT secretion via G-protein-coupled calcium-sensing receptors (CaR) 
(Brown and MacLeod, 2001; Fudge and Kovacs, 2004) and also CT gene expression 
is stimulated by elevated calcium, presumably via calcium-dependent activation of 
transcription factor TTF-1 (Suzuki et al., 1998). CaR activation triggers the PI3-Kβ 
signalling pathway and the downstream effector PKCζ, which results in increased 
secretion of CT from cultured thyroid C-cells (Liu et al., 2003). Interestingly, tyrosine 
kinase receptors have been shown to stimulate G-protein-coupled receptors to activate 
the ERK/MAPK pathway (Brown and MacLeod, 2001). Therefore, one potential 
mechanism of how GFRα4 might regulate CT synthesis could be to modulate the CaR 
signal transduction by Ret. C-cells express the PI3-kinase isoform (Liu et al., 2003), 
which could be synergistically activated through tyrosine kinase and G-protein-
coupled receptors. The function of PSPN in CT production requires clarification; 
however, our preliminary data indicate that CT levels are also decreased in juvenile 
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PSPN-KO mice (WT = 277 ± 136 ng/ml, KO = 137 ± 7 ng/ml, n = 7, p < 0.0001). 
Furthermore, it would be interesting to know whether enhanced Ret signalling in 
MTC caused by activating mutations in RET increases CT production in C-cells. Our 
results indicate that PSPN is able to activate phosphorylation of endogenous RET and 
downstream signalling in an established C-cell line with a MEN2A mutation in RET 
(IV; Suppl. Fig. 2). 
The spliced transcript of Pspn is barely detectable in the mouse thyroid and 
brain, in contrast to several other tissues such as the adrenal gland and fat (IV; Suppl. 
Fig. 3). Unlike other GDNF family ligands, PSPN does not bind to heparan sulfate 
proteoglycans in the tissue matrix and therefore could circulate through body fluids 
(Bespalov and Saarma, unpublished data). Possibly, a secreted form of PSPN could be 
released from adrenal gland into the bloodstream and might act like a hormone, 
binding to GFRα4 on the C-cell surface. Lack of good antibodies has prevented from 
determining which cells produce PSPN in young mice and whether PSPN levels are 
sufficient to support this hypothesis. The findings that PSPN-deficient mice are 
hypersensitive to cerebral ischaemia and that this neuronal cell death can be prevented 
by PSPN (Tomac et al. 2002), suggest that functional GFRα4, the only known 
receptor for PSPN, is expressed in the brain. However, results presented in study IV 
strongly suggest that functional GFRα4 is not produced in the mouse brain (IV; Fig. 
2E-H). On the other hand, Gfra1-2 and Ret expression levels have been shown to 
increase in neurons after brain insults, such as kindling epilepsy and cerebral ischemia 
(Kokaia et al., 1999; Arvidsson et al., 2001). Thus, it is possible that GFRα4 is 
upregulated in the brain after lesions. Future studies will reveal whether GFRα4-KO 
mice have a similar ischaemia phenotype to PSPN-KO mice.  
Chicken and mammalian GFRα4 differ in both their domain structure (Lindahl 
et al., 2000) and tissue expression patterns (Thompson et al., 1998; Homma et al., 
2000, 2003), implying that their biological functions are also different. Chicken Gfra4 
is expressed in several neuronal populations in the developing CNS, including 
motoneurons (Homma et al., 2000, 2003). Mammalian motoneurons do not express 
Gfra4 (Lindahl et al., 2000) and the only cells that express the functional form of 
GFRα4 in mouse seem to be the thyroid C-cells (IV). However, it is not known 
whether GFRα4 is expressed in ultimobranchial cells (source of CT in non-
mammalian vertebrates) in chicken (Airaksinen et al., 2006). D1 domain that is 
missing from GFRα4 of placental mammals is present in GFRα4 of all other 
vertebrate classes (including marsupials) as well as in all other GFRα receptors 
(Airaksinen et al., 2006). Furthermore, although chicken GFRα4 is able to bind 
human PSPN (Enokido et al., 1998), there is no PSPN orthologue in the chicken 
genome (Airaksinen et al., 2006). Thus, compared with GFRα1 and GFRα2 
(Airaksinen and Saarma, 2002), the biological function of GFRα4 may be less 
conserved in vertebrate evolution. GDNF has previously been shown to regulate 
transmitter release at neuromuscular junctions (Ribchester et al., 1998) and from 
dopamine neurons (Yang et al., 2001), and NRTN can induce the release of substance 
P from enteric neurons (Heuckeroth et al., 1999). The present study indicates that 
GFRα4-mediated Ret signalling may regulate the production of a transmitter in vivo, 
suggesting that signalling through other GFRα receptors may regulate transmitter 
synthesis in other cells.  
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CONCLUSIONS 
 
1) GFRα2-mediated signalling was found to be essential for parasympathetic neuron 
survival and innervation in the exocrine pancreas and for a subpopulation of enteric 
neurons in the small intestine. The combination of impaired secretion of the salivary 
gland and the exocrine pancreas and possibly intestinal dysmotility contribute to 
growth retardation in GFRα2-KO mice (I). 
 
2) The size and target innervation by cholinergic but not noradrenergic sympathetic 
neurons require GFRα2 (II). 
 
3) GFRα2-mediated signalling is needed to maintain the size and terminal innervation 
of non-peptidergic cutaneous nociceptors in vivo. Deficient nociceptor development is 
associated with impaired inflammatory pain responses and enhanced thermal 
avoidance (III).  
 
4) The functional form of GFRα4 seems to be restricted in thyroid C-cells of the 
mouse (IV).  
 
5) Impaired thyroid calcitonin production is accompanied by increased bone 
formation in juvenile GFRα4-KO mice. The expression of this phenotype correlates 
with the co-expression of functional GFRα4 and Ret of C-cells in young mice (IV). 
 
Taken together, the results presented here together with previous studies show 
that GFRα2/Ret signalling is crucial for the development of cholinergic autonomic 
neurons. These include most parasympathetic and cholinergic sympathetic neurons as 
well as a subpopulation of enteric neurons. Depending on the target tissue, GFRα2-
mediated signalling is necessary for trophic support of the neurons and for target 
innervation or maintenance. Deficits in autonomic innervation lead to various 
functional impairments in GFRα2-KO mice. This study also established a novel role 
for GDNF family receptors, namely GFRα4, in regulating transmitter production. 
Thus, GFRα2/Ret signalling may have clinical potential in such conditions as 
intestinal dysmotility, exocrinopathies and neuropathic pain, and GFRα4/Ret 
signalling may be implicated in osteoporosis. 
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